{"meta":{"query_hash":"79cc2530f486","filters":{"venue":"Expert Review of Hematology"},"cohort_total":73,"direct_labels_cover":0,"predictions_cover":73,"exported":73,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/79cc2530f486","api":"https://metacan.xera.ac/api/v1/cohort?venue=Expert+Review+of+Hematology"},"results":[{"id":"W1856197384","doi":"10.1586/17474086.2015.1071186","title":"Infectious complications in children with acute lymphoblastic leukemia treated in low-middle-income countries","year":2015,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":42,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medicine; Intensive care medicine; Lymphoblastic Leukemia; Disease; Poverty; Infectious disease (medical specialty); Economic shortage; Pediatrics; Immunology; Leukemia; Internal medicine; Economic growth","score_opus":0.02188836468672579,"score_gpt":0.3468926346957215,"score_spread":0.32500427000899573,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1856197384","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00040467316,0.9948953,0.000012033661,0.0001332872,0.00008951724,0.0030336084,0.00004371409,0.00006288415,0.0013249743],"genre_scores_gemma":[0.00028417326,0.99689925,0.00007751606,0.00043246473,0.00005089946,0.0018295461,0.00029754813,0.00006949679,0.00005908932],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9971518,0.0002617018,0.0014349,0.0005414099,0.00023148098,0.00037871502],"domain_scores_gemma":[0.99804944,0.00015039794,0.00063444994,0.00080498273,0.00021281163,0.00014791705],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021925282,0.0005384068,0.004809243,0.00054439186,0.00003937062,0.0000080712,0.00024022975,0.00030844595,0.00012423132],"category_scores_gemma":[0.00007190021,0.00037307283,0.00031451695,0.0011694129,0.00024967655,0.0000694701,0.00007217008,0.00043210105,0.00013601259],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00019251318,0.0016303582,0.098707296,0.7432661,0.0042937496,0.0009966181,0.00031037684,0.0000040218188,9.9827e-7,0.007171949,0.0069442736,0.13648175],"study_design_scores_gemma":[0.0016991051,0.00032919899,0.0012180347,0.4224303,0.0014386198,0.018616825,0.0000039480533,0.0000010772839,0.0000036984998,0.00001448143,0.5538335,0.00041120572],"about_ca_topic_score_codex":0.00038342932,"about_ca_topic_score_gemma":0.0002463148,"teacher_disagreement_score":0.54688925,"about_ca_system_score_codex":0.0011183325,"about_ca_system_score_gemma":0.0018847929,"threshold_uncertainty_score":0.99987215},"labels":[],"label_agreement":null},{"id":"W1948056367","doi":"10.1586/17474086.2015.1049594","title":"Supportive medical care for children with acute lymphoblastic leukemia in low- and middle-income countries","year":2015,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":33,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto; SickKids Foundation","funders":"","keywords":"Medicine; Intensive care medicine; Lymphoblastic Leukemia; Anemia; Palliative care; Tumor lysis syndrome; Supportive psychotherapy; Health care; Pediatrics; Leukemia; Internal medicine; Nursing; Chemotherapy","score_opus":0.020152062845790405,"score_gpt":0.3622676101564847,"score_spread":0.34211554731069427,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1948056367","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000825733,0.9936089,0.000099732264,0.00027077788,0.00012163485,0.005438996,0.00019224513,0.000038876435,0.00014629096],"genre_scores_gemma":[0.000027852962,0.9954304,0.0012509142,0.0006251059,0.00017049124,0.0015113449,0.00077051367,0.00013914092,0.00007420847],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99477136,0.0003232047,0.0019933644,0.0009499154,0.0011291476,0.0008329864],"domain_scores_gemma":[0.9960234,0.0010615572,0.0008058916,0.00083267456,0.0006733351,0.0006031506],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008424199,0.00083570764,0.008126898,0.00044189554,0.000051963107,0.000011463265,0.0005476939,0.00090012426,0.000187763],"category_scores_gemma":[0.0014856857,0.0005214163,0.00044141719,0.0005062654,0.000897532,0.00007737235,0.00032434435,0.0005728295,0.000041050585],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002936635,0.0000754872,0.00021056115,0.9241304,0.0015206509,0.0015816513,0.0004981999,2.7803106e-8,2.412309e-8,0.00055900245,0.0044879317,0.06664243],"study_design_scores_gemma":[0.0035939496,0.0008013781,0.0000128961165,0.60838485,0.0017237331,0.024382805,0.000067876055,0.000011541783,0.0000042892734,0.000009374968,0.36056268,0.0004446488],"about_ca_topic_score_codex":0.00008694095,"about_ca_topic_score_gemma":0.00004410959,"teacher_disagreement_score":0.35607475,"about_ca_system_score_codex":0.0026613977,"about_ca_system_score_gemma":0.020160398,"threshold_uncertainty_score":0.99972373},"labels":[],"label_agreement":null},{"id":"W1969524425","doi":"10.1586/17474086.2014.873699","title":"The emerging role of carfilzomib combination therapy in the management of multiple myeloma","year":2014,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hotel Dieu Hospital","funders":"","keywords":"Carfilzomib; Medicine; Bortezomib; Proteasome inhibitor; Multiple myeloma; Pharmacology; Oncology; Refractory (planetary science); Clinical trial; Internal medicine; Biology","score_opus":0.038215541105202006,"score_gpt":0.40029644227368966,"score_spread":0.3620809011684877,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1969524425","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007303985,0.99458444,0.000006934079,0.00033117188,0.000059018235,0.0035220124,0.0000058254363,0.0000061309474,0.0014114437],"genre_scores_gemma":[0.0012843559,0.9972848,0.00028078744,0.00007672999,0.000020357798,0.00085988845,0.00009314983,0.00002751118,0.00007238296],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966951,0.0008153667,0.0014061276,0.00027150885,0.00048926007,0.00032261753],"domain_scores_gemma":[0.9971481,0.00082293147,0.0008741779,0.0009443977,0.00016509024,0.000045302837],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012266956,0.00030392435,0.0027778805,0.0001601953,0.000054282253,0.0000034813963,0.00053243723,0.00012937264,0.000044346947],"category_scores_gemma":[0.00019745687,0.0001391592,0.00061244733,0.0004079593,0.00018904149,0.000022706765,0.00011058721,0.00022495548,0.000010106718],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000032800253,0.0002963887,0.00010201382,0.12788507,0.0005615378,0.000029635057,0.00014129937,7.969573e-9,0.0000018707303,0.0063767442,0.00044186314,0.86413074],"study_design_scores_gemma":[0.0012142601,0.00025545587,0.000121809535,0.09372468,0.00022291813,0.000117946365,0.00021442997,0.000008733115,0.000072041,0.000064491585,0.90388703,0.000096218835],"about_ca_topic_score_codex":0.00007833582,"about_ca_topic_score_gemma":0.000007525552,"teacher_disagreement_score":0.9034451,"about_ca_system_score_codex":0.000046442474,"about_ca_system_score_gemma":0.000090796806,"threshold_uncertainty_score":0.5674747},"labels":[],"label_agreement":null},{"id":"W1970311996","doi":"10.1586/17474086.1.1.75","title":"Risk of heparin-induced thrombocytopenia in patients receiving thromboprophylaxis","year":2008,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":41,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hamilton Health Sciences","funders":"","keywords":"Medicine; Heparin; Heparin-induced thrombocytopenia; Platelet; Thrombosis; Platelet factor 4; Platelet activation; Discovery and development of direct thrombin inhibitors; Internal medicine; Low molecular weight heparin; Thrombin; Surgery","score_opus":0.04446902066069388,"score_gpt":0.36745661531091617,"score_spread":0.3229875946502223,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1970311996","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.004866186,0.98658186,0.0000028169718,0.00005184497,0.0006308796,0.0044225194,0.00004430773,0.00005645431,0.0033431293],"genre_scores_gemma":[0.0032849503,0.9944442,0.0011738173,0.00018362395,0.00010004072,0.00033628196,0.0002418786,0.0001978846,0.0000373418],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.990921,0.0012518865,0.004818615,0.0013250288,0.0007824429,0.00090102316],"domain_scores_gemma":[0.992984,0.0006544132,0.0032499474,0.0023074788,0.00049599755,0.0003081551],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00072147354,0.0012829603,0.018010346,0.00080568466,0.000093469054,0.0000070290994,0.00089974666,0.0011644315,0.0005220226],"category_scores_gemma":[0.0018608329,0.0009852963,0.0021846993,0.0016129003,0.00037828242,0.0001659128,0.00050540484,0.0014271061,0.0001973321],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000046467638,0.0018950349,0.0068560224,0.29499498,0.0015296004,0.00010915578,0.0003172009,1.5596655e-8,0.000031046584,0.0003836234,0.002767078,0.6910698],"study_design_scores_gemma":[0.002222905,0.0014406014,0.0071349465,0.4215458,0.001815703,0.0008486207,0.000019680376,8.35461e-7,0.00043224095,0.000028301061,0.563337,0.0011733383],"about_ca_topic_score_codex":0.00045729155,"about_ca_topic_score_gemma":0.000042894524,"teacher_disagreement_score":0.6898964,"about_ca_system_score_codex":0.00039446482,"about_ca_system_score_gemma":0.0012080651,"threshold_uncertainty_score":0.99999225},"labels":[],"label_agreement":null},{"id":"W1975247464","doi":"10.1586/ehm.10.54","title":"Fondaparinux: does it cause HIT? can it treat HIT?","year":2010,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":89,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences; Hamilton Regional Laboratory Medicine Program","funders":"","keywords":"Fondaparinux; Medicine; Heparin-induced thrombocytopenia; Heparin; Immunogenicity; Anticoagulant; Antibody; Immunology; Internal medicine; Thrombosis; Venous thromboembolism","score_opus":0.07088286175210595,"score_gpt":0.4156462738865622,"score_spread":0.34476341213445627,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1975247464","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000021877142,0.97675943,0.0000036345903,0.0064828196,0.0013086322,0.00313675,0.000058289486,0.00011273051,0.012115824],"genre_scores_gemma":[0.00002714663,0.99072933,0.0008373974,0.0042756945,0.0004877095,0.0008687415,0.00044561466,0.00022014431,0.0021082093],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99353135,0.0005521477,0.0030696075,0.0013269022,0.0005263158,0.0009937003],"domain_scores_gemma":[0.99441427,0.0005583678,0.001405119,0.0027186975,0.0003005742,0.00060297933],"candidate_categories":["metaepi_narrow","research_integrity","insufficient_payload"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00060566707,0.0013835748,0.0137824565,0.00042471252,0.00012850833,0.000021333555,0.0008827287,0.0015396825,0.0040189475],"category_scores_gemma":[0.0009018179,0.0008382899,0.0021652607,0.0006136012,0.00045534913,0.000093370276,0.00038057865,0.0016102465,0.0006925819],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000011682686,0.00046156335,0.000029159231,0.34064084,0.0011137085,0.00050895975,0.0002868576,8.525609e-10,0.000045949462,0.002293339,0.07503858,0.57956934],"study_design_scores_gemma":[0.00044591993,0.00017162044,0.00000221482,0.18448369,0.0033789463,0.004138791,0.000033083434,1.4172677e-7,0.00021599433,0.000021345755,0.80648273,0.0006255308],"about_ca_topic_score_codex":0.00031217615,"about_ca_topic_score_gemma":0.00043478113,"teacher_disagreement_score":0.7314441,"about_ca_system_score_codex":0.0002567656,"about_ca_system_score_gemma":0.0015591809,"threshold_uncertainty_score":0.99989146},"labels":[],"label_agreement":null},{"id":"W1979172522","doi":"10.1586/17474086.2014.873285","title":"Multiple myeloma: genome sequencing, drug development and the future outlook","year":2014,"lang":"en","type":"article","venue":"Expert Review of Hematology","topic":"Protein Degradation and Inhibitors","field":"Biochemistry, Genetics and Molecular Biology","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute; Leukemia and Lymphoma Society; Multiple Myeloma Research Foundation","keywords":"Medicine; Family medicine; Multiple myeloma; Library science; Oncology; Internal medicine; Gerontology","score_opus":0.006525124098754515,"score_gpt":0.2456722739160622,"score_spread":0.23914714981730767,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1979172522","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.094322346,0.89435595,0.001796257,0.006337403,0.00038259692,0.0007904237,0.000002469159,0.000019401028,0.001993139],"genre_scores_gemma":[0.8256498,0.1358358,0.017676748,0.018092752,0.0009124697,0.00038234444,0.00020007782,0.00004828118,0.0012017487],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99907094,0.00017235796,0.000329797,0.00021030124,0.00008234317,0.00013426835],"domain_scores_gemma":[0.999424,0.000025576473,0.0001476844,0.0003002616,0.000059558224,0.00004295303],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00043721762,0.00012471463,0.0003175019,0.000017167218,0.000068770125,0.0000044106955,0.00016358678,0.00007075779,0.000026445496],"category_scores_gemma":[0.00019168184,0.00007645321,0.00006914616,0.000038270842,0.00015711183,0.0000025941322,0.000103939194,0.00005886772,0.000009863936],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00054118724,0.00034549207,0.0039223023,0.016640518,0.00079465815,0.000019144954,0.0065041063,0.0000022917318,0.3892783,0.0975336,0.2532066,0.2312118],"study_design_scores_gemma":[0.00053504837,0.000020365187,0.000059935574,0.00022586502,0.000005561764,0.00006767643,0.00008806505,0.000007883028,0.14004865,0.00003240933,0.85880506,0.00010348709],"about_ca_topic_score_codex":0.0000047222793,"about_ca_topic_score_gemma":0.000014908618,"teacher_disagreement_score":0.7585202,"about_ca_system_score_codex":0.000007845822,"about_ca_system_score_gemma":0.000056962053,"threshold_uncertainty_score":0.31176713},"labels":[],"label_agreement":null},{"id":"W1997682944","doi":"10.1586/ehm.12.10","title":"Bleeding risk assessment during oral anticoagulant therapy initiation","year":2012,"lang":"en","type":"editorial","venue":"Expert Review of Hematology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Western University","funders":"","keywords":"Medicine; Oral anticoagulant; Intensive care medicine; Venous thromboembolism; Anticoagulant therapy; Risk assessment; Anticoagulant; Warfarin; Surgery; Internal medicine; Thrombosis; Atrial fibrillation","score_opus":0.05970464769289128,"score_gpt":0.42719482262660036,"score_spread":0.36749017493370906,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W1997682944","genre_codex":"editorial","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013488088,0.42971224,0.00019512365,0.0016547786,0.563646,0.0016259514,0.00001860558,0.0001012367,0.0016972229],"genre_scores_gemma":[0.0024427976,0.5917852,0.0017981828,0.0001854709,0.4030745,0.00002269964,0.0004456813,0.000049600265,0.00019583141],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99745816,0.00023857554,0.001026283,0.00031952304,0.0006429938,0.0003144825],"domain_scores_gemma":[0.99769163,0.00045808448,0.0010555316,0.00042907926,0.00027860387,0.0000870472],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0008039802,0.00033427268,0.0019506159,0.00019383669,0.000078025376,0.000010675823,0.00013851452,0.00042708145,0.0006495477],"category_scores_gemma":[0.0008854671,0.00024997487,0.00042915597,0.00016484241,0.000054279953,0.00012432912,0.00009398441,0.00040943726,0.000040097733],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009482309,0.000039235118,0.02023258,0.015848711,0.00052403176,0.000022429798,0.00009897764,1.07843334e-7,0.00021030802,0.00049535494,0.9592036,0.0032298616],"study_design_scores_gemma":[0.0014993172,0.00011384589,0.002397418,0.008459868,0.00038574572,0.000025125939,0.000022145925,0.000005640553,0.00042143336,0.000021076501,0.9864036,0.00024482445],"about_ca_topic_score_codex":0.000027044074,"about_ca_topic_score_gemma":9.4661505e-7,"teacher_disagreement_score":0.16207299,"about_ca_system_score_codex":0.00009507093,"about_ca_system_score_gemma":0.00014864058,"threshold_uncertainty_score":0.99999523},"labels":[],"label_agreement":null},{"id":"W2019408825","doi":"10.1586/ehm.11.5","title":"Quebec platelet disorder","year":2011,"lang":"en","type":"article","venue":"Expert Review of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":47,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier Universitaire Sainte-Justine; McMaster University","funders":"Canadian Institutes of Health Research","keywords":"Pathogenesis; Medicine; Mutation; Gene; Platelet; Cancer research; Fibrinolysis; Activator (genetics); Plasminogen activator; Platelet disorder; Genetics; Immunology; Biology; Internal medicine","score_opus":0.023699298015248994,"score_gpt":0.3143188883507248,"score_spread":0.2906195903354758,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2019408825","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.19450186,0.7800791,0.00011303065,0.0016582927,0.00018460478,0.0007110736,0.0000038274693,0.000057833284,0.022690356],"genre_scores_gemma":[0.627492,0.35309768,0.0073438277,0.01018905,0.00005049603,0.00020544347,0.00010980728,0.00005800187,0.0014536754],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99914426,0.000031948817,0.00035468815,0.00018259525,0.000098551645,0.00018795396],"domain_scores_gemma":[0.99943626,0.000024205108,0.00010536236,0.00031575956,0.000051750227,0.00006663389],"candidate_categories":["insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00005834159,0.00013967553,0.0008138777,0.00004555247,0.000020117724,7.794052e-7,0.0000768031,0.00007406587,0.0016716138],"category_scores_gemma":[0.00005019438,0.00009633835,0.0001477942,0.00009823928,0.000081517464,0.00003720114,0.000028105445,0.00006734418,0.00017811451],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007774996,0.008968745,0.09257395,0.043762796,0.0023457825,0.01080863,0.005155018,3.272877e-8,0.0006977863,0.09063051,0.23990238,0.5043769],"study_design_scores_gemma":[0.005515178,0.0010339643,0.011530329,0.016439632,0.00029583584,0.011463248,0.00038935777,0.000009815068,0.017157981,0.001003926,0.9345404,0.00062032207],"about_ca_topic_score_codex":0.0011469569,"about_ca_topic_score_gemma":0.00012967059,"teacher_disagreement_score":0.694638,"about_ca_system_score_codex":0.000011460373,"about_ca_system_score_gemma":0.000051824958,"threshold_uncertainty_score":0.999241},"labels":[],"label_agreement":null},{"id":"W2054095502","doi":"10.1586/17474086.2014.965140","title":"Anti-infective prophylaxis in pediatric patients with acute myeloid leukemia","year":2014,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Neutropenia and Cancer Infections","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children","funders":"","keywords":"Medicine; Myeloid leukemia; Antibiotic prophylaxis; Antibiotics; Bacteremia; Intensive care medicine; Myeloid; Internal medicine; Immunology; Microbiology","score_opus":0.012770121401791897,"score_gpt":0.3329687169134856,"score_spread":0.3201985955116937,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054095502","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00024719973,0.9946243,0.000020026635,0.00004094882,0.00032574366,0.0032202005,0.000015013916,0.0000377039,0.0014688266],"genre_scores_gemma":[0.0001404408,0.99788356,0.00017902056,0.00036128005,0.00018814254,0.0009705337,0.00015063719,0.000080450125,0.00004593823],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.997069,0.00033415292,0.0012837381,0.00063182577,0.00029466013,0.00038662806],"domain_scores_gemma":[0.9978063,0.00016610409,0.00089558685,0.00074971636,0.00025203635,0.00013023247],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00021119951,0.00056899997,0.006112315,0.00043211985,0.000039726056,0.0000048272077,0.00022241558,0.00035842368,0.00019129727],"category_scores_gemma":[0.00012573603,0.00035311774,0.00060539716,0.0009674823,0.000120310615,0.00006119511,0.00009012417,0.00065567304,0.00013626274],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00003078906,0.00044731775,0.007953429,0.5309819,0.0005205491,0.00016056409,0.00004894235,3.2276244e-8,2.1004789e-7,0.00034662688,0.0059429216,0.45356673],"study_design_scores_gemma":[0.0008150567,0.00086613174,0.00047923598,0.105178975,0.0017171042,0.000656862,0.0000013429038,4.824752e-8,0.0000040324285,0.0000037703546,0.8899329,0.00034456892],"about_ca_topic_score_codex":0.000031298576,"about_ca_topic_score_gemma":0.000009542477,"teacher_disagreement_score":0.88398993,"about_ca_system_score_codex":0.00035060002,"about_ca_system_score_gemma":0.0011205572,"threshold_uncertainty_score":0.99989206},"labels":[],"label_agreement":null},{"id":"W2054623522","doi":"10.1586/ehm.11.59","title":"Treatment of warfarin-associated coagulopathy with vitamin K","year":2011,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Atrial Fibrillation Management and Outcomes","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Warfarin; Medicine; Prothrombin complex concentrate; Coagulopathy; Clotting factor; Fresh frozen plasma; Oral anticoagulant; Anticoagulant; Vitamin; Prothrombin time; Anesthesia; Surgery; Internal medicine; Atrial fibrillation; Platelet","score_opus":0.1111017497580846,"score_gpt":0.40938071076811033,"score_spread":0.2982789610100257,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2054623522","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000003708426,0.99504536,0.000015847003,0.00017185313,0.00019357498,0.0021651017,0.000008645242,0.000033678312,0.00236221],"genre_scores_gemma":[0.000010095824,0.9976309,0.00071841874,0.000074760996,0.00009312574,0.000061468745,0.00023205519,0.000049479495,0.0011296931],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976446,0.00021646089,0.0013840512,0.00033481687,0.00019421917,0.00022582481],"domain_scores_gemma":[0.9975452,0.00022085891,0.001398625,0.0006149809,0.00014376915,0.000076581695],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001565103,0.0004537009,0.0067230696,0.00019902871,0.000020307047,0.0000014804875,0.00013473243,0.00024329033,0.00044253],"category_scores_gemma":[0.00014727464,0.0002543251,0.0010271518,0.00033836602,0.00012239424,0.000025821997,0.000046417215,0.0000769499,0.00005287369],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000044352997,0.00014841252,0.00058322743,0.23407836,0.0014543193,0.000079641955,0.00011925918,3.1014835e-9,4.058419e-7,0.0030467582,0.0022517736,0.7581935],"study_design_scores_gemma":[0.0006884139,0.0008653318,0.000011554586,0.104118064,0.0027039084,0.00023877222,0.000009767625,1.4205523e-7,0.0000147344845,0.000004144901,0.8911684,0.0001767338],"about_ca_topic_score_codex":0.000028306782,"about_ca_topic_score_gemma":0.0000035571888,"teacher_disagreement_score":0.8889167,"about_ca_system_score_codex":0.00009876124,"about_ca_system_score_gemma":0.00021404953,"threshold_uncertainty_score":0.9999909},"labels":[],"label_agreement":null},{"id":"W2076008996","doi":"10.1586/ehm.12.8","title":"Therapeutic potential of mitochondrial translation inhibition for treatment of acute myeloid leukemia","year":2012,"lang":"en","type":"editorial","venue":"Expert Review of Hematology","topic":"Mitochondrial Function and Pathology","field":"Biochemistry, Genetics and Molecular Biology","cited_by":23,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; Ontario Institute for Cancer Research","funders":"National Cancer Institute; Canadian Institutes of Health Research","keywords":"Medicine; Myeloid leukemia; Translation (biology); Cancer research; Myeloid; Leukemia; Oncology; Pharmacology; Internal medicine; Gene; Messenger RNA; Genetics","score_opus":0.015857131548587863,"score_gpt":0.3113172917942411,"score_spread":0.29546016024565325,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2076008996","genre_codex":"editorial","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0004146823,0.46077228,0.02741602,0.00016817954,0.5078803,0.0022765438,0.0008894085,0.000012584972,0.00017001457],"genre_scores_gemma":[0.0009184713,0.548986,0.017359542,0.00019694891,0.41593847,0.0008444047,0.015217904,0.0001321599,0.00040609375],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9977968,0.00024360963,0.0010713153,0.00041491358,0.00022224181,0.00025115104],"domain_scores_gemma":[0.9979987,0.00012408971,0.00093941623,0.0004972974,0.00038385694,0.00005662603],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00015273204,0.00034748335,0.0014272755,0.00009355901,0.000030001851,0.0000019257852,0.00015031561,0.001128047,0.00011055255],"category_scores_gemma":[0.00010931477,0.00029018865,0.0007381866,0.000070659036,0.00016264137,0.000005279693,0.0000243014,0.000078218894,0.0000031697305],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000893148,0.0001889359,0.0000017250367,0.003331788,0.00046839876,0.000001474148,0.00007087131,5.379847e-7,0.6293926,0.00009805322,0.36049658,0.0050558704],"study_design_scores_gemma":[0.0015991986,0.0015899782,4.1067833e-7,0.0006795522,0.0005115417,0.000035686997,0.000007062782,0.0000022169359,0.28973708,0.000033430748,0.70562536,0.00017851214],"about_ca_topic_score_codex":0.00002126875,"about_ca_topic_score_gemma":0.000008022599,"teacher_disagreement_score":0.34512874,"about_ca_system_score_codex":0.00003747655,"about_ca_system_score_gemma":0.00036637924,"threshold_uncertainty_score":0.999955},"labels":[],"label_agreement":null},{"id":"W2096795054","doi":"10.1586/ehm.09.8","title":"Preventing thrombophilia-related complications of pregnancy","year":2009,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University Medical Centre; McMaster University; Hamilton General Hospital","funders":"","keywords":"Medicine; Thrombophilia; Placental abruption; Pregnancy; Preeclampsia; Obstetrics; Intrauterine growth restriction; Antiphospholipid syndrome; Venous thromboembolism; Gynecology; Fetus; Thrombosis; Internal medicine","score_opus":0.06763437100397245,"score_gpt":0.4046199351107086,"score_spread":0.33698556410673614,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2096795054","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[4.476439e-7,0.9917708,0.000092254566,0.0003595199,0.00016237816,0.002372952,0.0000100905945,0.000055693927,0.005175887],"genre_scores_gemma":[0.000018763127,0.99592274,0.003106045,0.00031515738,0.000024740188,0.00017909291,0.00024833874,0.0000467929,0.00013833362],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.9963493,0.0002968305,0.0024068002,0.00043852357,0.00026418656,0.00024436472],"domain_scores_gemma":[0.9966006,0.00016336297,0.0018555049,0.0010499703,0.00023274998,0.00009778324],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00026378862,0.00040845922,0.005826353,0.00020814089,0.00003912556,0.0000019826196,0.0003004797,0.00040430698,0.00057264965],"category_scores_gemma":[0.00022699936,0.00031087466,0.0011868523,0.0005376369,0.00011821291,0.0000362157,0.00007942825,0.00030438925,0.000067262816],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[6.6312265e-7,0.0003962931,0.0000017596512,0.2959297,0.00037163202,0.000005811727,0.00003573674,5.2977676e-9,0.0000125164015,0.029326359,0.0012211344,0.6726984],"study_design_scores_gemma":[0.00020001568,0.00011417542,0.0000054897573,0.5385039,0.0012786431,0.0006254144,0.0000037202788,0.0000010631636,0.000056630066,0.00039107955,0.45866123,0.00015865498],"about_ca_topic_score_codex":0.0000029022308,"about_ca_topic_score_gemma":3.3255432e-7,"teacher_disagreement_score":0.6725398,"about_ca_system_score_codex":0.000031721385,"about_ca_system_score_gemma":0.00027841004,"threshold_uncertainty_score":0.9999343},"labels":[],"label_agreement":null},{"id":"W2102038897","doi":"10.1586/ehm.13.18","title":"Preventing thrombophilia-related complications of pregnancy: an update","year":2013,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Blood Coagulation and Thrombosis Mechanisms","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Thrombosis and Atherosclerosis Research Institute; McMaster University","funders":"","keywords":"Medicine; Thrombophilia; Pregnancy; Antiphospholipid syndrome; Observational study; Obstetrics; Lupus anticoagulant; Intensive care medicine; Surgery; Thrombosis; Internal medicine","score_opus":0.07406171112022669,"score_gpt":0.404382092805826,"score_spread":0.3303203816855993,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102038897","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000002840932,0.9945324,0.00010958853,0.00030811407,0.00021452479,0.0031736176,0.00001612539,0.00006678554,0.0015760058],"genre_scores_gemma":[0.000026434369,0.99304193,0.005333617,0.00032098952,0.000028196822,0.0005043543,0.00057218276,0.00007301068,0.00009929049],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99608225,0.00044198986,0.002415125,0.00052024255,0.0002653546,0.00027506723],"domain_scores_gemma":[0.99609303,0.00011991315,0.0019582955,0.0013668818,0.000312999,0.00014888284],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00029375148,0.00045225344,0.005556801,0.00020497863,0.000047431928,0.000003934607,0.00038846442,0.00042883496,0.0016661758],"category_scores_gemma":[0.00015101906,0.00033573245,0.00087985385,0.0004481279,0.00016103176,0.00008949776,0.00012529765,0.0003139807,0.0001964335],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[6.9348476e-7,0.0005279174,0.0000032131404,0.3296389,0.00056056725,0.000004148681,0.00006062533,9.2514085e-9,0.00003447406,0.04144992,0.0015373374,0.6261822],"study_design_scores_gemma":[0.00023903156,0.00013390933,0.0000040088444,0.45930558,0.0014288458,0.0005544164,0.000008942565,0.0000054039915,0.000104525265,0.0005007906,0.5374839,0.00023067943],"about_ca_topic_score_codex":0.0000090572885,"about_ca_topic_score_gemma":7.8567945e-7,"teacher_disagreement_score":0.6259515,"about_ca_system_score_codex":0.000028953315,"about_ca_system_score_gemma":0.0002721265,"threshold_uncertainty_score":0.99990946},"labels":[],"label_agreement":null},{"id":"W2102066474","doi":"10.1586/ehm.10.60","title":"Philadelphia chromosome-positive acute lymphoblastic leukemia in children: new and emerging treatment options","year":2010,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":18,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Children's Hospital","funders":"","keywords":"Medicine; Dasatinib; Philadelphia chromosome; Nilotinib; Imatinib; Oncology; Chemotherapy; Internal medicine; Acute lymphocytic leukemia; Hematopoietic stem cell transplantation; Transplantation; Imatinib mesylate; Chemotherapy regimen; Regimen; Leukemia; Lymphoblastic Leukemia; Myeloid leukemia; Chromosomal translocation","score_opus":0.019400866095464,"score_gpt":0.34919228973256367,"score_spread":0.3297914236370997,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2102066474","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008602602,0.9951677,0.000011350113,0.00050842843,0.00022444056,0.0036459446,0.000070676404,0.00005055449,0.00023490435],"genre_scores_gemma":[0.000014905942,0.9960875,0.0015601128,0.00030062784,0.00026411822,0.0006203284,0.0008261839,0.00011416277,0.0002120475],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9962329,0.00022354821,0.0017272558,0.00096533936,0.00026441095,0.00058650854],"domain_scores_gemma":[0.99746513,0.00028591865,0.0008265619,0.0010066901,0.0000649797,0.00035072627],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00014681982,0.0009949276,0.006622604,0.00045279358,0.0000643508,0.000008747433,0.0002440551,0.0006764314,0.00046407065],"category_scores_gemma":[0.00014570828,0.0007145192,0.000830085,0.000509709,0.00023155929,0.00007585353,0.00015257343,0.0005487057,0.00010323699],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000021427692,0.00030593047,0.000075225755,0.046912808,0.0022918277,0.00051725394,0.00017633251,9.369812e-8,0.0000070350857,0.0005017076,0.0026701756,0.9465202],"study_design_scores_gemma":[0.0030152323,0.0005124228,0.000034774734,0.2303184,0.0048961914,0.025645085,0.000007094722,0.000005462335,0.000035360517,0.00001334965,0.73499084,0.0005258151],"about_ca_topic_score_codex":0.00030462584,"about_ca_topic_score_gemma":0.000025792026,"teacher_disagreement_score":0.9459944,"about_ca_system_score_codex":0.0032453865,"about_ca_system_score_gemma":0.004266069,"threshold_uncertainty_score":0.9995306},"labels":[],"label_agreement":null},{"id":"W2105235256","doi":"10.1586/17474086.2013.827413","title":"Practical management of patients with myelofibrosis receiving ruxolitinib","year":2013,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Cancer Institute","keywords":"Ruxolitinib; Medicine; Myelofibrosis; Adverse effect; Extramedullary hematopoiesis; Anemia; Constitutional symptoms; Internal medicine; Randomized controlled trial; Clinical trial; Intensive care medicine; Bone marrow; Oncology; Disease; Haematopoiesis; Stem cell","score_opus":0.048357737867579915,"score_gpt":0.39484366910145563,"score_spread":0.3464859312338757,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2105235256","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000015873577,0.99205446,0.000030314926,0.0004376432,0.00011526088,0.0046333116,0.000031069,0.000020708741,0.002661329],"genre_scores_gemma":[0.000009041834,0.97184,0.02536995,0.00028276246,0.000037308848,0.0019129664,0.00035588534,0.00006853307,0.00012350883],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99653274,0.00031499556,0.0017028697,0.0005897197,0.00049350015,0.0003661636],"domain_scores_gemma":[0.99674064,0.0004717379,0.0013996162,0.0008434394,0.00037366888,0.00017088349],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00021352108,0.0006081019,0.005861697,0.00015116522,0.000034696564,0.0000053504664,0.0001589984,0.00024573863,0.0013574559],"category_scores_gemma":[0.00015708532,0.00034590473,0.00064326933,0.00030103713,0.00016128342,0.000064957305,0.00013807231,0.00024803623,0.00012522265],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000022308046,0.0010730877,0.0005354426,0.462372,0.0014799354,0.0000700254,0.000022702992,1.1647499e-9,2.3060489e-8,0.0042485786,0.014212537,0.5159634],"study_design_scores_gemma":[0.00052621815,0.00044880004,0.00012879234,0.35211486,0.002005257,0.00017763813,0.000010986897,7.500103e-8,0.000015079623,0.0000036920605,0.64438033,0.00018827809],"about_ca_topic_score_codex":0.000008145319,"about_ca_topic_score_gemma":4.4707818e-7,"teacher_disagreement_score":0.6301678,"about_ca_system_score_codex":0.00009927467,"about_ca_system_score_gemma":0.00020321667,"threshold_uncertainty_score":0.99989927},"labels":[],"label_agreement":null},{"id":"W2111763904","doi":"10.1586/ehm.11.45","title":"Platelet-type von Willebrand disease update: the disease, the molecule and the animal model","year":2011,"lang":"en","type":"editorial","venue":"Expert Review of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University","funders":"","keywords":"Medicine; Platelet; Von Willebrand disease; Platelet membrane glycoprotein; Glycoprotein; Von Willebrand factor; Disease; Immunology; Platelet Glycoprotein GPIb-IX Complex; Platelet disorder; Internal medicine; Molecular biology; Biology","score_opus":0.010869868000023639,"score_gpt":0.2962629254472423,"score_spread":0.28539305744721866,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2111763904","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011471228,0.93936306,0.000015681473,0.0128572965,0.043677524,0.0021052528,0.00011331424,0.000027992855,0.00069276395],"genre_scores_gemma":[0.011890585,0.95147973,0.000065607,0.0054668896,0.02930365,0.000498177,0.00069860264,0.000098398275,0.00049834984],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99774826,0.00029447096,0.0006217254,0.00048070314,0.0005014754,0.0003533634],"domain_scores_gemma":[0.9975459,0.00054984604,0.00039233142,0.0011042306,0.0002007386,0.00020697467],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003874334,0.0004740144,0.0015674911,0.000038422124,0.00021079647,0.0000154525,0.0004659517,0.00024702316,0.00013921369],"category_scores_gemma":[0.0010299566,0.0001821816,0.0003666095,0.00013319364,0.000845758,0.0000476317,0.00020902752,0.00053490273,0.00003417491],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00240146,0.0001662178,0.000029969691,0.0031025438,0.00041727844,0.0003863229,0.00015418902,1.7073405e-7,0.0000011177633,0.0027191741,0.9900462,0.00057537766],"study_design_scores_gemma":[0.003534562,0.0001415857,0.00002504972,0.00472368,0.00147612,0.0001690514,0.000027642454,0.0002999123,0.000019559979,0.0016498729,0.9876513,0.00028164653],"about_ca_topic_score_codex":0.00005678941,"about_ca_topic_score_gemma":0.0000070077085,"teacher_disagreement_score":0.014373872,"about_ca_system_score_codex":0.00002143588,"about_ca_system_score_gemma":0.00046459635,"threshold_uncertainty_score":0.742915},"labels":[],"label_agreement":null},{"id":"W2114583616","doi":"10.1586/17474086.2014.951322","title":"Alprolix (recombinant Factor IX Fc fusion protein): extended half-life product for the prophylaxis and treatment of hemophilia B","year":2014,"lang":"en","type":"article","venue":"Expert Review of Hematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Factor IX; Recombinant DNA; Genetic enhancement; Fusion protein; Coagulation; Disease; Internal medicine; Immunology; Pharmacology; Gene","score_opus":0.03703268248659912,"score_gpt":0.35180181884704737,"score_spread":0.31476913636044823,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2114583616","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.40001774,0.54865426,0.000099252655,0.037062056,0.0002824222,0.0135840485,0.000014139659,0.000042934727,0.00024315974],"genre_scores_gemma":[0.8968131,0.09744286,0.0022285348,0.00028148975,0.00017505737,0.0018444043,0.000036728394,0.000041138755,0.0011366769],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9982087,0.00016545183,0.0006253875,0.00040933563,0.00026789712,0.00032322636],"domain_scores_gemma":[0.9984414,0.0002606224,0.00023303567,0.00068383873,0.00023754554,0.00014357663],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003401145,0.00025945218,0.0012531605,0.00008228218,0.00009635274,0.0000036879171,0.00012864555,0.00009768805,0.00013690883],"category_scores_gemma":[0.00074592483,0.00012119647,0.0002512512,0.00014218254,0.00026957368,0.00003233277,0.000052388692,0.00008033454,0.000010441252],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0020532082,0.004965435,0.004864045,0.050934494,0.0009742108,0.000044786346,0.0018982422,6.102283e-8,0.05083341,0.005907269,0.005187916,0.8723369],"study_design_scores_gemma":[0.011994723,0.032082267,0.005033773,0.014788044,0.00050996605,0.00089326716,0.00019458865,0.00030900005,0.4213871,0.0007882264,0.51136655,0.00065249787],"about_ca_topic_score_codex":0.000047019617,"about_ca_topic_score_gemma":0.000005208685,"teacher_disagreement_score":0.87168443,"about_ca_system_score_codex":0.000040555147,"about_ca_system_score_gemma":0.00016473122,"threshold_uncertainty_score":0.49422485},"labels":[],"label_agreement":null},{"id":"W2115740244","doi":"10.1586/ehm.10.68","title":"Older patients with acute myeloid leukemia","year":2010,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Medicine; Myeloid leukemia; Disease; Oncology; Tolerability; Induction chemotherapy; Clinical trial; Internal medicine; Chemotherapy; Intensive care medicine; Adverse effect","score_opus":0.020115558474148244,"score_gpt":0.363715221955897,"score_spread":0.34359966348174875,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2115740244","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00000996178,0.99197286,0.000030019137,0.00037380095,0.00035851452,0.004519519,0.0000512633,0.00007573036,0.0026083053],"genre_scores_gemma":[5.838233e-7,0.9913658,0.0042023407,0.0014591729,0.00021160385,0.0008021156,0.0010093334,0.0002113909,0.00073768705],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952111,0.0003432524,0.001829463,0.00096772524,0.0008355437,0.0008128843],"domain_scores_gemma":[0.99546653,0.00036052236,0.0011104209,0.002037199,0.0006277419,0.00039760332],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00044885924,0.0009566723,0.0084167775,0.0004131636,0.00006940658,0.000009854716,0.00079369254,0.0010424022,0.0018088885],"category_scores_gemma":[0.000430695,0.000563413,0.0010577524,0.00073444453,0.00053254265,0.00008771361,0.00033479626,0.0020723396,0.00054061017],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000031698666,0.00015196277,0.000023126788,0.25100777,0.0007724002,0.0003304313,0.000026976057,4.6539503e-10,5.927024e-7,0.00023755545,0.050782174,0.6966353],"study_design_scores_gemma":[0.0008934869,0.00025794227,0.000006217393,0.21622218,0.0015469037,0.0027712395,0.000002878414,2.2521438e-7,0.000011511421,0.0000023899065,0.7779066,0.00037843382],"about_ca_topic_score_codex":0.000019635938,"about_ca_topic_score_gemma":0.0000024494893,"teacher_disagreement_score":0.7271244,"about_ca_system_score_codex":0.00056663976,"about_ca_system_score_gemma":0.0034741962,"threshold_uncertainty_score":0.9996817},"labels":[],"label_agreement":null},{"id":"W2116119814","doi":"10.1586/ehm.12.56","title":"Clinical causes and treatment of the thrombotic storm","year":2012,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":34,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Catastrophic antiphospholipid syndrome; Thrombosis; Antiphospholipid syndrome; Thrombophilia; Coagulopathy; Internal medicine; Cardiology; Intensive care medicine","score_opus":0.11783865859256074,"score_gpt":0.4478899808725514,"score_spread":0.3300513222799907,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2116119814","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000028082535,0.9958901,0.0000014551154,0.00041868672,0.00066025776,0.0024489937,0.0000074594427,0.000011630937,0.00053337164],"genre_scores_gemma":[0.00003952159,0.99858886,0.00025863483,0.0005465459,0.00019030352,0.00024492852,0.000017633176,0.00003764457,0.00007591244],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99722564,0.00038881018,0.001607715,0.00032865469,0.0001942221,0.000254931],"domain_scores_gemma":[0.9974925,0.00036429765,0.0009950555,0.0009713557,0.0000649337,0.0001118686],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00037816458,0.00038300588,0.007479327,0.000066385284,0.0000334185,0.0000018032401,0.00018493831,0.0002436075,0.00026035597],"category_scores_gemma":[0.00014229555,0.00018366052,0.0011685613,0.00014609062,0.0003409598,0.000020751588,0.00015035992,0.00013555137,0.000023882583],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000016556519,0.0011376023,0.00030210504,0.21257964,0.0009260674,0.000008837847,0.0000854592,6.6855166e-10,7.599711e-8,0.0021352665,0.006094683,0.77672863],"study_design_scores_gemma":[0.00021685725,0.00035772807,0.00029967946,0.12274961,0.005332653,0.00029909835,0.0000130070175,3.573082e-8,0.0000028373058,0.0000049502705,0.8706073,0.00011624049],"about_ca_topic_score_codex":0.00004695969,"about_ca_topic_score_gemma":0.000013818645,"teacher_disagreement_score":0.8645126,"about_ca_system_score_codex":0.000063418134,"about_ca_system_score_gemma":0.00019527748,"threshold_uncertainty_score":0.7489459},"labels":[],"label_agreement":null},{"id":"W2118890264","doi":"10.1586/17474086.2015.978281","title":"Risk factors for relapse in childhood acute lymphoblastic leukemia: prediction and prevention","year":2014,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":44,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; SickKids Foundation; University of Toronto","funders":"","keywords":"Medicine; Lymphoblastic Leukemia; Disease; Intensive care medicine; Oncology; Pediatrics; Internal medicine; Leukemia","score_opus":0.020466678903095628,"score_gpt":0.35586712279538013,"score_spread":0.3354004438922845,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2118890264","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000083356004,0.9922879,0.0016596101,0.00006848877,0.00028748452,0.0052966448,0.00012930168,0.000049853857,0.00013740067],"genre_scores_gemma":[0.000028286295,0.9956615,0.0017373562,0.000115032235,0.0001796011,0.0012532537,0.00073255633,0.00011723237,0.00017519211],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9953426,0.0006192789,0.0021787751,0.00088423555,0.00040788372,0.0005671981],"domain_scores_gemma":[0.99576974,0.0018075292,0.0012215332,0.00080217264,0.00016941667,0.00022962867],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009778187,0.00067903707,0.0060094944,0.0005341356,0.00006853521,0.000008526387,0.000284138,0.0008913964,0.000066684486],"category_scores_gemma":[0.0033426024,0.00047960845,0.0009036611,0.0003781418,0.00022656137,0.00008504991,0.00017844168,0.00061129633,0.000020353105],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007125485,0.00024238898,0.0001414956,0.45326868,0.0011213279,0.00005071766,0.00019400849,1.5986527e-7,9.51471e-7,0.00035147215,0.013363538,0.53119403],"study_design_scores_gemma":[0.002646322,0.00091784867,0.000051263785,0.2992586,0.0033514,0.0026622433,0.000024836127,0.00009851602,0.000009428049,0.00011690648,0.690516,0.00034662546],"about_ca_topic_score_codex":0.000044038297,"about_ca_topic_score_gemma":0.0000060213297,"teacher_disagreement_score":0.67715245,"about_ca_system_score_codex":0.0011877771,"about_ca_system_score_gemma":0.0018898515,"threshold_uncertainty_score":0.9997656},"labels":[],"label_agreement":null},{"id":"W2122385972","doi":"10.1586/17474086.2013.842124","title":"Thrombosis in pediatric cancer: identifying the risk factors to improve care","year":2013,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":43,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Asymptomatic; Cancer; Pediatric cancer; Intensive care medicine; Pediatrics; Thrombosis; Complication; Childhood cancer; Population; Surgery; Internal medicine; Environmental health","score_opus":0.050631895932307845,"score_gpt":0.4054087468857177,"score_spread":0.3547768509534099,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2122385972","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000119422664,0.9913651,0.000007241214,0.00046181053,0.0010321989,0.006530462,0.000034917175,0.000031989013,0.00041685993],"genre_scores_gemma":[0.000051651004,0.9946277,0.00021695551,0.00090787053,0.0002818757,0.003732565,0.000060457434,0.00008436697,0.000036540834],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99629855,0.00040941365,0.001678121,0.00071219454,0.0003678122,0.00053391815],"domain_scores_gemma":[0.997133,0.00034870688,0.0010461487,0.0011488888,0.00016365247,0.00015960168],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00038820945,0.00063644786,0.0065584485,0.00037549014,0.00008261048,0.000016387941,0.00060950563,0.0002942726,0.00061642646],"category_scores_gemma":[0.00039103194,0.0003492037,0.0010569863,0.0007691264,0.00006486589,0.0000550636,0.00038371893,0.00043346977,0.00017592675],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000010010137,0.00016318378,0.0006268667,0.47705743,0.00036857944,0.00001234047,0.001070251,8.7004295e-8,1.9646554e-7,0.00020168615,0.046189114,0.47430927],"study_design_scores_gemma":[0.0001371402,0.00010340544,0.00029120315,0.12049893,0.0030904096,0.000014499324,0.0003374209,1.7420294e-7,0.0000074777276,0.000005087362,0.87521,0.00030424562],"about_ca_topic_score_codex":0.002014083,"about_ca_topic_score_gemma":0.00011732887,"teacher_disagreement_score":0.8290209,"about_ca_system_score_codex":0.00025323653,"about_ca_system_score_gemma":0.0003067047,"threshold_uncertainty_score":0.999896},"labels":[],"label_agreement":null},{"id":"W2134879438","doi":"10.1586/ehm.11.41","title":"Inherited platelet disorders: a clinical approach to diagnosis and management","year":2011,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":32,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Hospital for Sick Children; Izaak Walton Killam Health Centre; Dalhousie University","funders":"","keywords":"Medicine; Platelet; Platelet disorder; Blood Platelet Disorders; Mucocutaneous zone; Immunology; Pathology; Intensive care medicine; Bioinformatics; Disease; Platelet aggregation","score_opus":0.09485437774920512,"score_gpt":0.41991313772120553,"score_spread":0.3250587599720004,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2134879438","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000008645432,0.98724955,0.000035682235,0.00021751078,0.00015458591,0.004665136,0.000017011485,0.00003923091,0.007612626],"genre_scores_gemma":[0.000001643029,0.98885065,0.006650536,0.0014789902,0.00003684495,0.0025750927,0.00022438788,0.00006960311,0.00011225255],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9967668,0.0002705649,0.0016389956,0.0007922952,0.00016327544,0.00036808397],"domain_scores_gemma":[0.99827915,0.00016997951,0.00047935144,0.00076140324,0.000043063184,0.0002670653],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003362512,0.00057755667,0.0064303568,0.00022999512,0.000034692574,0.0000050467474,0.00023509932,0.0003985406,0.00013340518],"category_scores_gemma":[0.00013731375,0.0003906412,0.0007833044,0.0003647181,0.00014610251,0.00003063209,0.00024639862,0.0002792177,0.00011376622],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012346168,0.0010030875,0.00006421792,0.22502615,0.0009206193,0.00016667285,0.000032570002,3.4106687e-10,9.971516e-10,0.0008772723,0.017305067,0.754592],"study_design_scores_gemma":[0.00057197374,0.00027459345,0.000011796014,0.1339296,0.0012461242,0.001161139,0.000011698726,1.9387427e-7,1.15917466e-7,0.000027476817,0.8625104,0.0002549078],"about_ca_topic_score_codex":0.000026470248,"about_ca_topic_score_gemma":0.0000032569037,"teacher_disagreement_score":0.8452053,"about_ca_system_score_codex":0.000029018907,"about_ca_system_score_gemma":0.00006220543,"threshold_uncertainty_score":0.99985456},"labels":[],"label_agreement":null},{"id":"W2137678379","doi":"10.1586/ehm.10.15","title":"Hemophilia: basic and translational science","year":2010,"lang":"en","type":"article","venue":"Expert Review of Hematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Session (web analytics); Hemostasis; Translational research; Translational science; Internal medicine; Pathology","score_opus":0.02436481757706234,"score_gpt":0.37643952530807245,"score_spread":0.35207470773101013,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2137678379","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6462291,0.28135708,0.0000315579,0.056071095,0.00031908974,0.00093502435,0.0000033762308,0.00003634031,0.015017356],"genre_scores_gemma":[0.9427989,0.047549512,0.0075529083,0.0016036681,0.00010989384,0.000041562347,0.00001063927,0.000011818159,0.00032111388],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.9991277,0.000017839306,0.00022188075,0.00020013085,0.00025613984,0.00017632982],"domain_scores_gemma":[0.9994082,0.00007499354,0.000036423622,0.00022830354,0.00012778117,0.00012432889],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003582824,0.0000802715,0.00037685898,0.00009526289,0.00006016575,0.0000022508937,0.00007654839,0.000053121676,0.00062801916],"category_scores_gemma":[0.00023393723,0.00005224321,0.00005798393,0.00021191289,0.00072065956,0.00005176989,0.00002700159,0.00014944618,0.000024464363],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00014938774,0.0011009461,0.11909862,0.023887921,0.00015755555,0.00035162445,0.0009690241,1.3494612e-8,0.42205036,0.2262958,0.013731702,0.19220704],"study_design_scores_gemma":[0.005972279,0.0010984589,0.061666537,0.014750569,0.00021859574,0.01716696,0.000121225356,0.00020540682,0.40341663,0.0031084672,0.49155197,0.0007229114],"about_ca_topic_score_codex":0.000003961936,"about_ca_topic_score_gemma":0.0000017438397,"teacher_disagreement_score":0.47782025,"about_ca_system_score_codex":0.000004074122,"about_ca_system_score_gemma":0.00020843284,"threshold_uncertainty_score":0.687637},"labels":[],"label_agreement":null},{"id":"W2139055966","doi":"10.1586/17474086.2013.841538","title":"Bendamustine for indolent non-Hodgkin lymphoma in the front-line or relapsed setting: a review of pharmacokinetics and clinical trial outcomes","year":2013,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital","funders":"","keywords":"Bendamustine; Medicine; Tolerability; Clinical trial; Oncology; Pharmacokinetics; Refractory (planetary science); Pharmacology; Internal medicine; Lymphoma; Rituximab; Adverse effect","score_opus":0.11394806879692908,"score_gpt":0.4874092623334129,"score_spread":0.3734611935364838,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2139055966","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000050995608,0.9791405,0.000010895833,0.0038659566,0.00055844866,0.016192405,0.000078277,0.000013279438,0.00008919688],"genre_scores_gemma":[0.000007731706,0.9853189,0.0033117395,0.0060562347,0.0002704525,0.004557476,0.00034094256,0.00006463286,0.000071887654],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9921234,0.0010369761,0.0052749785,0.00071909226,0.00041920447,0.00042630726],"domain_scores_gemma":[0.9916357,0.0042842706,0.0026079621,0.0010606572,0.0002516307,0.0001598077],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002555492,0.0007662982,0.011025778,0.00016954252,0.000034852936,0.0000065279123,0.00045037415,0.00043206092,0.0003010143],"category_scores_gemma":[0.0032070763,0.0003548979,0.001900218,0.00027836516,0.00022931844,0.000034134344,0.00016861354,0.00026294915,0.000017689617],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00042081237,0.0013990669,0.000055692723,0.39981073,0.00051531213,0.00006042319,0.00003026635,8.6692226e-10,3.8159964e-8,0.00004664253,0.04058098,0.55708003],"study_design_scores_gemma":[0.021279374,0.0014435495,0.000019970008,0.3735369,0.0035599524,0.0005157904,0.000011880659,0.000002087129,0.0000030099905,0.000002615637,0.5994407,0.00018414878],"about_ca_topic_score_codex":0.00003221218,"about_ca_topic_score_gemma":0.0000054350357,"teacher_disagreement_score":0.5588597,"about_ca_system_score_codex":0.00010321896,"about_ca_system_score_gemma":0.00075848337,"threshold_uncertainty_score":0.9998903},"labels":[],"label_agreement":null},{"id":"W2144345143","doi":"10.1586/ehm.09.23","title":"Iron overload in myelodysplastic syndromes","year":2009,"lang":"en","type":"editorial","venue":"Expert Review of Hematology","topic":"Iron Metabolism and Disorders","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Myelodysplastic syndromes; Intensive care medicine; Internal medicine; Bone marrow","score_opus":0.009037749780192532,"score_gpt":0.32531710460791313,"score_spread":0.3162793548277206,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2144345143","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00008355068,0.698316,0.0000078301655,0.0007234785,0.29717267,0.00056223787,0.000013691764,0.00002689577,0.0030936608],"genre_scores_gemma":[0.00011859045,0.8440955,0.00075577275,0.0016314344,0.15196037,0.000094471,0.00051212055,0.00006033926,0.00077136763],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972034,0.00016375334,0.0011122298,0.00050813745,0.0005929855,0.000419466],"domain_scores_gemma":[0.99820036,0.00046895898,0.00041197077,0.00066999986,0.00013579808,0.000112945054],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00032616415,0.00043227983,0.0029966852,0.00028129367,0.000018329905,0.0000034276532,0.0002543715,0.00082984706,0.00062474667],"category_scores_gemma":[0.002749097,0.00034581745,0.00031600028,0.00024808236,0.00013615935,0.00004486081,0.00005798324,0.00066506834,0.0001344858],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000061020826,0.00019640935,0.000032018957,0.035936788,0.000014363845,0.00023527071,0.00005746394,4.2313353e-8,0.0000140389175,0.00034773236,0.959508,0.0035968265],"study_design_scores_gemma":[0.0012846116,0.00022989632,0.00008139387,0.02946544,0.00016957875,0.00020502368,0.00002655691,4.5992053e-7,0.000025358242,0.000059489637,0.9681844,0.00026775475],"about_ca_topic_score_codex":0.00007126749,"about_ca_topic_score_gemma":0.000011046926,"teacher_disagreement_score":0.14577955,"about_ca_system_score_codex":0.000054159766,"about_ca_system_score_gemma":0.00049322285,"threshold_uncertainty_score":0.9998994},"labels":[],"label_agreement":null},{"id":"W2154259107","doi":"10.1586/17474086.2015.995623","title":"In the realms of future: new frontiers of ‘techno-oncology’ as a platform for global improvement in the outcomes of childhood cancer","year":2014,"lang":"en","type":"editorial","venue":"Expert Review of Hematology","topic":"Childhood Cancer Survivors' Quality of Life","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Izaak Walton Killam Health Centre","funders":"","keywords":"Medicine; Pace; Childhood cancer; Scope (computer science); Developing country; Pediatric oncology; Cancer; Oncology; Economic growth; Internal medicine","score_opus":0.015479382834199166,"score_gpt":0.38650303567240335,"score_spread":0.3710236528382042,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2154259107","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.002946601,0.66430795,0.00013529215,0.05851075,0.26531446,0.0078313155,0.00037107413,0.000018833365,0.00056374114],"genre_scores_gemma":[0.008344552,0.6518563,0.008579236,0.033052936,0.29322332,0.0038269435,0.0007939115,0.00020393617,0.00011884758],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99468654,0.00032865274,0.0029213605,0.0005029436,0.0011328126,0.00042769636],"domain_scores_gemma":[0.99425036,0.0014317478,0.002621092,0.0013253214,0.00030275976,0.00006873974],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.002973124,0.00048978796,0.004821405,0.00017130442,0.00002246809,0.0000023833038,0.0012376324,0.00093429105,0.000040456398],"category_scores_gemma":[0.0025948726,0.0002790682,0.0007514268,0.00045391696,0.0003361264,0.000050844024,0.00012967433,0.0006896448,7.324839e-7],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00029335913,0.00062427425,0.0006749664,0.0140332915,0.00043716177,0.0000057422026,0.0043732403,1.204698e-7,0.000010234208,0.002445255,0.9694349,0.007667437],"study_design_scores_gemma":[0.0045898063,0.0020175267,0.00043370077,0.010222007,0.00049379264,0.00004832506,0.0033491713,9.786112e-7,0.00046454062,0.001521181,0.9765953,0.0002636617],"about_ca_topic_score_codex":0.0068257824,"about_ca_topic_score_gemma":0.0031944963,"teacher_disagreement_score":0.027908865,"about_ca_system_score_codex":0.00025429393,"about_ca_system_score_gemma":0.0021837573,"threshold_uncertainty_score":0.99996614},"labels":[],"label_agreement":null},{"id":"W2159451755","doi":"10.1586/17474086.2013.859520","title":"1:1:1 – Warranted or wasteful? Even where appropriate, high ratio transfusion protocols are costly: early transition to individualized care benefits patients and transfusion services","year":2013,"lang":"en","type":"editorial","venue":"Expert Review of Hematology","topic":"Trauma, Hemostasis, Coagulopathy, Resuscitation","field":"Medicine","cited_by":13,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"St. Michael's Hospital; Health Sciences Centre; Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Intensive care medicine; Blood transfusion; Surgery","score_opus":0.013558157180038591,"score_gpt":0.31263003160428343,"score_spread":0.2990718744242448,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2159451755","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.26693726,0.26361114,0.0007446992,0.0074623474,0.19398114,0.26296327,0.0034895495,0.000681163,0.00012942446],"genre_scores_gemma":[0.024652991,0.5737119,0.020189987,0.0051251184,0.15017942,0.18649285,0.037831932,0.0016047569,0.00021107234],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9938328,0.00065417675,0.0020404079,0.0012874352,0.0015936493,0.00059150945],"domain_scores_gemma":[0.99531466,0.0003560304,0.0009372833,0.0008044486,0.0022105798,0.0003769865],"candidate_categories":["metaepi_narrow","research_integrity"],"consensus_categories":[],"category_scores_codex":[0.00036740254,0.0009285434,0.0034194123,0.00041612377,0.00018561531,0.000058810663,0.00040779085,0.0015345226,0.0002494158],"category_scores_gemma":[0.00037646352,0.000720309,0.00034030672,0.0005749927,0.00010945387,0.00039077204,0.000065642635,0.00076209055,0.000034979614],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008827854,0.0016420211,0.0009209584,0.45632523,0.00064477057,0.000099946665,0.039971814,0.0000022098923,0.002374935,0.000040823335,0.18390204,0.3052474],"study_design_scores_gemma":[0.036399297,0.010255937,0.004930727,0.46261904,0.0020309791,0.00014290486,0.006562729,0.000026446496,0.010156339,0.00004421995,0.46393856,0.0028928195],"about_ca_topic_score_codex":0.00077539677,"about_ca_topic_score_gemma":0.0009360133,"teacher_disagreement_score":0.31010076,"about_ca_system_score_codex":0.00018389497,"about_ca_system_score_gemma":0.00035956793,"threshold_uncertainty_score":0.9997617},"labels":[],"label_agreement":null},{"id":"W2161640233","doi":"10.1586/ehm.11.27","title":"Biomarkers in chronic graft-versus-host disease","year":2011,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Children's Hospital; University of British Columbia","funders":"National Cancer Institute","keywords":"Medicine; Disease; Hematopoietic stem cell transplantation; Graft-versus-host disease; Pathophysiology; Immunology; Intensive care medicine; Bioinformatics; Immune system; Transplantation; Pathology; Internal medicine; Biology","score_opus":0.05880769473109391,"score_gpt":0.38881828105228394,"score_spread":0.33001058632119,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2161640233","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000010854575,0.9936137,0.00003258097,0.00015956408,0.0005548046,0.002816732,0.000026110734,0.00004603947,0.0027493346],"genre_scores_gemma":[0.000004719916,0.99799293,0.0005465182,0.0002071317,0.000089914756,0.0006341416,0.0003788289,0.00009094832,0.00005487608],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9961851,0.00042396953,0.0019867357,0.00066819205,0.0002689915,0.00046700527],"domain_scores_gemma":[0.99749357,0.00041160293,0.0006876792,0.001033345,0.00008131584,0.00029246876],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00045773777,0.0006128988,0.005094004,0.00041677908,0.000021001559,0.0000027938042,0.0003338244,0.0003897026,0.0013894349],"category_scores_gemma":[0.00027241017,0.00046419413,0.001011514,0.00056932034,0.00021253625,0.00004950568,0.00005802612,0.00035267163,0.00037780567],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000083557126,0.00014260027,0.000015348698,0.8213872,0.00046123462,0.0005337538,0.000061524544,1.406584e-9,0.0000014339454,0.0016932917,0.0027829327,0.17283717],"study_design_scores_gemma":[0.0006374626,0.000090102214,0.000004419671,0.3745155,0.0011359379,0.00050572125,0.000005510836,4.7529397e-7,0.000007529919,0.000004840959,0.6228631,0.00022935371],"about_ca_topic_score_codex":0.000037620597,"about_ca_topic_score_gemma":0.0000129719765,"teacher_disagreement_score":0.62008023,"about_ca_system_score_codex":0.00032764924,"about_ca_system_score_gemma":0.0014403713,"threshold_uncertainty_score":0.99978095},"labels":[],"label_agreement":null},{"id":"W2314236616","doi":"10.1586/ehm.11.65","title":"Stem cells and beyond: report on the 40th Annual Scientific Meeting of the International Society of Experimental Hematology","year":2011,"lang":"en","type":"article","venue":"Expert Review of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Stem cell; Haematopoiesis; Hematology; Stem cell biology; Context (archaeology); Medicine; Internal medicine; Biology; Genetics; Gene","score_opus":0.03806977854366482,"score_gpt":0.3371279983015401,"score_spread":0.2990582197578753,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2314236616","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.78386,0.18586199,0.0000307159,0.010711825,0.0011463037,0.001805434,0.00003376894,0.000024373698,0.01652554],"genre_scores_gemma":[0.98653436,0.007408101,0.0028081094,0.0024216492,0.000045773035,0.00008890326,0.000009155486,0.000026881517,0.00065709447],"study_design_codex":"not_applicable","study_design_gemma":"bench_or_experimental","domain_scores_codex":[0.99805206,0.00015987581,0.0008111384,0.00031792582,0.00045398858,0.0002050333],"domain_scores_gemma":[0.9981223,0.0002588799,0.0005814691,0.00068675063,0.000298748,0.000051876803],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0012156388,0.000145025,0.00072408083,0.000055615466,0.000074080934,0.0000027383905,0.00042986064,0.000095292584,0.00025468803],"category_scores_gemma":[0.00015613924,0.00007691451,0.00025237942,0.00018518863,0.0011020564,0.000040430532,0.00037704437,0.0002065655,0.000004163815],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003805677,0.0015503941,0.013444266,0.009561319,0.0009758049,0.00021712194,0.021862064,1.3511635e-7,0.29932314,0.08325696,0.566754,0.0026742562],"study_design_scores_gemma":[0.0004334667,0.00015356112,0.00010586022,0.0024851537,0.000029392766,0.0021151674,0.0035389136,0.00003313687,0.9771915,0.00004993244,0.013791379,0.00007251017],"about_ca_topic_score_codex":0.000036933263,"about_ca_topic_score_gemma":0.0000011763627,"teacher_disagreement_score":0.67786837,"about_ca_system_score_codex":0.000055749137,"about_ca_system_score_gemma":0.00025624395,"threshold_uncertainty_score":0.40605727},"labels":[],"label_agreement":null},{"id":"W2417014160","doi":"10.1080/17474086.2016.1198895","title":"Thrombotic thrombocytopenic pupura (TTP) dinner symposium proceedings","year":2016,"lang":"en","type":"article","venue":"Expert Review of Hematology","topic":"Complement system in diseases","field":"Immunology and Microbiology","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"St. Michael's Hospital","funders":"","keywords":"Thrombotic thrombocytopenic purpura; Medicine; Intensive care medicine; Alternative medicine; Thrombosis; Family medicine; Immunology; Internal medicine; Platelet; Pathology","score_opus":0.01774118943159769,"score_gpt":0.30316098061953295,"score_spread":0.28541979118793526,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2417014160","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.09099929,0.87031585,0.00017569722,0.022139402,0.0025584402,0.0024830722,0.00005462105,0.00031839797,0.010955244],"genre_scores_gemma":[0.95244503,0.044201452,0.0001566617,0.0015733677,0.000059552593,0.00032123417,0.00003000379,0.00004218672,0.0011705336],"study_design_codex":"bench_or_experimental","study_design_gemma":"not_applicable","domain_scores_codex":[0.99784213,0.00016354951,0.0009345628,0.0004870808,0.0000764619,0.0004961921],"domain_scores_gemma":[0.99855614,0.00025568876,0.0004339928,0.00051232945,0.0002007167,0.000041127612],"candidate_categories":["insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00030653214,0.00030214817,0.0012684729,0.00009432113,0.000092274226,0.0000053704057,0.0005857939,0.00016143265,0.0075200363],"category_scores_gemma":[0.000273595,0.00017918614,0.0002718698,0.0001588545,0.000378365,0.0001617683,0.0002581128,0.00009242142,0.0016467567],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000040734107,0.00027618886,0.00655307,0.005332585,0.00035446318,0.000008549229,0.00018622156,7.128077e-9,0.5624104,0.043558035,0.37984952,0.001430228],"study_design_scores_gemma":[0.0025426543,0.0004703826,0.0018201794,0.030885193,0.00023763909,0.0018398643,0.00022151902,2.9959656e-7,0.34125572,0.00071009935,0.6192061,0.00081040297],"about_ca_topic_score_codex":0.00001164439,"about_ca_topic_score_gemma":0.0000022676807,"teacher_disagreement_score":0.8614457,"about_ca_system_score_codex":0.00005882096,"about_ca_system_score_gemma":0.00006847547,"threshold_uncertainty_score":0.99913055},"labels":[],"label_agreement":null},{"id":"W2464396699","doi":"10.1080/17474086.2016.1208555","title":"Hematological disorders: a commonly unrecognized cause of acute stroke","year":2016,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Myeloproliferative Neoplasms: Diagnosis and Treatment","field":"Medicine","cited_by":88,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Heart and Stroke Foundation of Canada; American Heart Association","keywords":"Medicine; Stroke (engine); Etiology; Disease; Intensive care medicine; Venous thrombosis; Complication; Thrombosis; Pediatrics; Vascular disease; Internal medicine","score_opus":0.04934048004836651,"score_gpt":0.40804430130253555,"score_spread":0.35870382125416905,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2464396699","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000011754191,0.99283856,0.000045612534,0.0014761571,0.00024372514,0.0034119645,0.00030008046,0.000046247562,0.0016258719],"genre_scores_gemma":[0.000017849115,0.99565715,0.0017396712,0.000549241,0.00006672113,0.0014061091,0.0002906093,0.00007653833,0.00019610899],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99511874,0.00064398354,0.0025905077,0.0007456667,0.0004109311,0.00049020315],"domain_scores_gemma":[0.99546415,0.0012747255,0.0016622622,0.0011172041,0.0002492414,0.00023243696],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0003308914,0.00086681126,0.011781835,0.00024994634,0.000044820805,0.0000040768805,0.0003616366,0.00059147534,0.0017116835],"category_scores_gemma":[0.0004686552,0.0004548414,0.0020917878,0.0002882693,0.00039112996,0.000045964098,0.00020184652,0.0003555016,0.00020768697],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00006879657,0.0014961928,0.0003295727,0.29247555,0.0057890886,0.0003927827,0.00004627177,3.779834e-10,0.0000015198926,0.006121947,0.01860889,0.6746694],"study_design_scores_gemma":[0.001038297,0.0005194149,0.0000036662514,0.27682576,0.0033508597,0.0026397852,0.0000051512575,9.851532e-8,0.00008359859,0.00004471584,0.7152117,0.0002769916],"about_ca_topic_score_codex":0.000010723691,"about_ca_topic_score_gemma":0.000007025435,"teacher_disagreement_score":0.69660276,"about_ca_system_score_codex":0.00008933627,"about_ca_system_score_gemma":0.0004864415,"threshold_uncertainty_score":0.9997903},"labels":[],"label_agreement":null},{"id":"W2518117171","doi":"10.1080/17474086.2016.1232163","title":"Ponatinib in the therapy of chronic myeloid leukemia","year":2016,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":37,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Princess Margaret Cancer Centre","funders":"","keywords":"Ponatinib; Medicine; Magic bullet; Myeloid leukemia; Targeted therapy; Disease; Oncology; Tyrosine-kinase inhibitor; Nilotinib; Internal medicine; Immunology; Bioinformatics; Imatinib; Cancer","score_opus":0.0426814344624905,"score_gpt":0.38783313961551064,"score_spread":0.3451517051530201,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2518117171","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000006537613,0.992752,0.000004550406,0.00060173025,0.00022076827,0.003373649,0.000022938213,0.0000194491,0.0029983588],"genre_scores_gemma":[0.000012283153,0.99758995,0.00019250244,0.00077583647,0.00021119467,0.0008516969,0.00011592607,0.00007580711,0.00017482699],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99545383,0.0007501973,0.002278133,0.0005645128,0.00048509912,0.00046821198],"domain_scores_gemma":[0.9956497,0.0010902393,0.0013996525,0.0016731493,0.00011416556,0.00007311632],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0008614798,0.00065562624,0.0064938683,0.00026249146,0.00002366292,0.0000022980655,0.0007613556,0.00046567398,0.0013156878],"category_scores_gemma":[0.00038876696,0.00030437566,0.0012173683,0.00051967415,0.00031582642,0.000039199578,0.00010200272,0.0004809356,0.00015422],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012087367,0.00016694095,0.0000043130294,0.15194176,0.00029363064,0.000104633735,0.00008155237,2.0779563e-9,0.0000032089854,0.001001138,0.0077460837,0.8386446],"study_design_scores_gemma":[0.0011216692,0.0002630296,0.0000024131573,0.298613,0.0001602551,0.0019049937,0.000007193531,2.0779447e-7,0.00003341417,0.000017558297,0.6977192,0.00015702688],"about_ca_topic_score_codex":0.000050098017,"about_ca_topic_score_gemma":0.0000064909595,"teacher_disagreement_score":0.8384876,"about_ca_system_score_codex":0.0014887638,"about_ca_system_score_gemma":0.003991592,"threshold_uncertainty_score":0.9999408},"labels":[],"label_agreement":null},{"id":"W2526857253","doi":"10.1080/17474086.2016.1242404","title":"Immune checkpoint inhibitors in Hodgkin and non-Hodgkin lymphoma: how they work and when to use them","year":2016,"lang":"en","type":"editorial","venue":"Expert Review of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":10,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia; BC Cancer Agency","funders":"Canadian Institutes of Health Research; Michael Smith Health Research BC","keywords":"Medicine; Hodgkin lymphoma; Lymphoma; Immune system; Non-Hodgkin's lymphoma; Cancer research; Immunology; Immune checkpoint; Oncology; Immunotherapy","score_opus":0.014657470093788282,"score_gpt":0.29658655355149294,"score_spread":0.2819290834577047,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2526857253","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.033998538,0.7284473,0.000012406243,0.024546796,0.20806083,0.0043255924,0.00009445659,0.00006897246,0.00044507926],"genre_scores_gemma":[0.05369487,0.83090717,0.003834957,0.0014088199,0.107106194,0.0018644015,0.00022889797,0.00022543124,0.0007292579],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9969176,0.00021119099,0.0010918139,0.0008341387,0.00045510774,0.0004901202],"domain_scores_gemma":[0.996894,0.0012860906,0.00052142603,0.0008535199,0.0001882145,0.00025673246],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00056479854,0.00065541535,0.0031244273,0.00021559348,0.000043329266,0.000031366857,0.00019387926,0.0007315065,0.0000691421],"category_scores_gemma":[0.0016998439,0.00040475026,0.00029510865,0.00015198541,0.00017411231,0.000100021134,0.00033593015,0.00019424279,0.000029072673],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023892408,0.00046912744,0.0075072823,0.0058284495,0.00026218037,0.0003767139,0.0007579685,1.9202984e-9,0.00007750347,0.000108551605,0.951919,0.032454297],"study_design_scores_gemma":[0.0045138495,0.00043539194,0.0028000912,0.062827535,0.00020605754,0.0002305245,0.000044940876,1.2096022e-7,0.0020400845,0.000070922506,0.9263913,0.00043920949],"about_ca_topic_score_codex":0.00040171423,"about_ca_topic_score_gemma":0.000046607667,"teacher_disagreement_score":0.10245985,"about_ca_system_score_codex":0.00026553805,"about_ca_system_score_gemma":0.00029419162,"threshold_uncertainty_score":0.99984044},"labels":[],"label_agreement":null},{"id":"W2549399469","doi":"10.1080/17474086.2017.1257935","title":"Controversies in the management of cancer-associated thrombosis","year":2016,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Medicine; Cancer; Intensive care medicine; Thrombosis; Pulmonary embolism; Complication; Low molecular weight heparin; Chemotherapy; Heparin; Surgery; Internal medicine","score_opus":0.04198261433712888,"score_gpt":0.4110703301228576,"score_spread":0.36908771578572874,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2549399469","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000035228306,0.9891453,0.0000027404221,0.0028520843,0.00024964035,0.003043718,0.000029402965,0.00001097337,0.004662624],"genre_scores_gemma":[0.00002118239,0.9961856,0.00009656513,0.002370519,0.000039163035,0.0011465613,0.00003307668,0.000033152384,0.000074172116],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99711543,0.00035467118,0.0014632253,0.00036089553,0.0003692755,0.00033648364],"domain_scores_gemma":[0.99734896,0.0006390417,0.0011170955,0.00076322723,0.000091283284,0.000040386436],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006977452,0.0003848231,0.006176332,0.00017018899,0.000025098394,0.000002822356,0.0004835528,0.00019145264,0.00056468794],"category_scores_gemma":[0.00014841506,0.00019482434,0.00086279475,0.00039864678,0.0001600073,0.000021121221,0.00015527142,0.00016891907,0.000028186603],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000031757697,0.0006532501,0.000017614178,0.44456923,0.002319573,0.000053644373,0.00011323664,3.879415e-9,2.0976832e-7,0.01345992,0.07310354,0.46570662],"study_design_scores_gemma":[0.0003166114,0.00007324048,0.000038304657,0.38166755,0.0018176129,0.000013292272,0.000058766298,3.5640213e-8,0.0000018590674,0.000020400672,0.61588836,0.000103929946],"about_ca_topic_score_codex":0.00013220876,"about_ca_topic_score_gemma":0.000020684114,"teacher_disagreement_score":0.54278487,"about_ca_system_score_codex":0.00014151106,"about_ca_system_score_gemma":0.00011513421,"threshold_uncertainty_score":0.7944706},"labels":[],"label_agreement":null},{"id":"W2555762447","doi":"10.1080/17474086.2017.1259559","title":"Baby hamster kidney cell–derived recombinant factor VIII: a quarter century of learning and clinical experience","year":2016,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"Bayer","keywords":"Medicine; Recombinant DNA; Quarter (Canadian coin); Baby hamster kidney cell; Hamster; Internal medicine; Immunology; Biochemistry; Gene; Biology","score_opus":0.05976342074246231,"score_gpt":0.4400422264527192,"score_spread":0.38027880571025685,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2555762447","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013783273,0.9962241,0.00000802717,0.0007846952,0.00047845795,0.0016887606,0.000012800708,0.000022610391,0.0006426885],"genre_scores_gemma":[0.00008075833,0.998168,0.00034224868,0.00024856706,0.00010619434,0.00018935859,0.00006171795,0.00005666651,0.0007465058],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9952406,0.0009703754,0.002228994,0.0007168876,0.00035757723,0.00048554564],"domain_scores_gemma":[0.9969638,0.0008023856,0.00094798737,0.0006614998,0.00018154466,0.0004427609],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0004844822,0.0005342749,0.006062476,0.00019410824,0.000052440075,0.0000054339494,0.00025116408,0.00056899956,0.0010877425],"category_scores_gemma":[0.0009534847,0.00028125133,0.0011105146,0.00017993963,0.00054762064,0.00005464728,0.00020110671,0.0005756375,0.00014074042],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000045014724,0.00049103634,0.0008376091,0.2624281,0.00037029825,0.00016371114,0.00036051442,3.152704e-11,0.000037272446,0.00003620086,0.008522632,0.72670764],"study_design_scores_gemma":[0.00084087934,0.0005558747,0.0000059727568,0.21621275,0.00024086641,0.00042884814,0.000057380243,2.0720005e-7,0.00009164955,0.0000016399524,0.7813658,0.00019810977],"about_ca_topic_score_codex":0.0000050976605,"about_ca_topic_score_gemma":2.0845411e-7,"teacher_disagreement_score":0.7728432,"about_ca_system_score_codex":0.000052342053,"about_ca_system_score_gemma":0.0005200154,"threshold_uncertainty_score":0.99996394},"labels":[],"label_agreement":null},{"id":"W2565168385","doi":"10.1080/17474086.2017.1272410","title":"The current state of adverse event reporting in hemophilia","year":2016,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"","keywords":"Medicine; Adverse effect; Intensive care medicine; Current (fluid); Event (particle physics); Internal medicine","score_opus":0.07319955231219018,"score_gpt":0.46441864070533156,"score_spread":0.3912190883931414,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2565168385","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000016137468,0.99575967,0.0000033435651,0.000936631,0.00033562735,0.002427388,0.000009603102,0.0000113002,0.00050033024],"genre_scores_gemma":[0.000015032352,0.9988326,0.00007321116,0.000033440545,0.0000726566,0.00036822513,0.000035423407,0.000038997357,0.0005304226],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99330586,0.0004863901,0.004842218,0.00042710107,0.0004676309,0.00047079558],"domain_scores_gemma":[0.99437016,0.0006852795,0.0036114284,0.0009976823,0.0002089302,0.00012649898],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0021390554,0.00039342057,0.004891464,0.00021597007,0.000039939976,0.000001166031,0.00030866748,0.000115906805,0.00010245787],"category_scores_gemma":[0.0027212175,0.00017042174,0.001240882,0.00038011296,0.0002855921,0.00002581627,0.00018016313,0.00045889334,0.00009659167],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000100733205,0.0001280578,0.000042590822,0.20400345,0.0001238164,0.00016496057,0.000021939082,1.6355061e-9,6.872563e-7,0.00010308917,0.0018537169,0.79354763],"study_design_scores_gemma":[0.00019161095,0.000053681706,0.000005252782,0.34720427,0.00011578746,0.00040797138,0.0000020716523,2.3021443e-7,0.000021695145,0.00005653685,0.65184987,0.00009103614],"about_ca_topic_score_codex":0.0000058572,"about_ca_topic_score_gemma":0.0000037653178,"teacher_disagreement_score":0.79345655,"about_ca_system_score_codex":0.00015534405,"about_ca_system_score_gemma":0.001009958,"threshold_uncertainty_score":0.6949597},"labels":[],"label_agreement":null},{"id":"W2769988410","doi":"10.1080/17474086.2018.1407241","title":"Duration of anticoagulant therapy in pediatric venous thromboembolism: Current approaches and updates from randomized controlled trials","year":2017,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":20,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Randomized controlled trial; Venous thromboembolism; Duration (music); Incidence (geometry); Intensive care medicine; Pediatrics; Population; Clinical trial; Anticoagulant therapy; Surgery; Internal medicine; Thrombosis","score_opus":0.174496993218688,"score_gpt":0.4352950980767897,"score_spread":0.2607981048581017,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2769988410","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00013894166,0.9844902,0.000026945208,0.0003304802,0.0005995268,0.0141266845,0.00003001125,0.000017340619,0.0002398582],"genre_scores_gemma":[0.0003178658,0.99629706,0.0003480521,0.00010775037,0.00032741198,0.002216593,0.00032848894,0.000051995914,0.0000047522763],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9899246,0.002976243,0.0057643494,0.000635959,0.00037940513,0.00031946308],"domain_scores_gemma":[0.98918974,0.0032137355,0.0064212517,0.0009501557,0.00013009066,0.00009499905],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.006298145,0.0007008298,0.055123176,0.0004928796,0.000050071503,0.000019162435,0.0003438867,0.00034390614,0.00013651703],"category_scores_gemma":[0.0046858448,0.00038737687,0.002587279,0.00015724506,0.00027407362,0.00006808712,0.0001327456,0.0003074837,0.00000766356],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0023247872,0.0024406891,0.00002186118,0.21923132,0.0030490349,0.00002746957,0.00029763437,2.2265446e-8,7.1651874e-7,0.002860844,0.001996321,0.7677493],"study_design_scores_gemma":[0.1822285,0.00057879736,0.00009335619,0.3370216,0.026617976,0.00013023238,0.000042355026,0.000017753571,0.00002381104,0.0005132439,0.4519363,0.0007960651],"about_ca_topic_score_codex":0.00011196559,"about_ca_topic_score_gemma":0.000005065908,"teacher_disagreement_score":0.76695323,"about_ca_system_score_codex":0.000034963814,"about_ca_system_score_gemma":0.00035402222,"threshold_uncertainty_score":0.99985784},"labels":[],"label_agreement":null},{"id":"W2896637894","doi":"10.1080/17474086.2018.1537778","title":"Optimal frontline management of mantle cell lymphoma: can we agree?","year":2018,"lang":"en","type":"editorial","venue":"Expert Review of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Mantle cell lymphoma; Mantle (geology); Intensive care medicine; Lymphoma; Oncology; Cancer research; Internal medicine; Geochemistry; Geology","score_opus":0.01045945692812617,"score_gpt":0.30996336456101303,"score_spread":0.29950390763288687,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2896637894","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00022197611,0.76586986,0.000016304033,0.0013740503,0.22586796,0.0012558354,0.0001557662,0.00003129639,0.005206963],"genre_scores_gemma":[0.00038789609,0.87664455,0.009903574,0.00033399867,0.10894918,0.00039020047,0.0009836924,0.00008658644,0.0023203082],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9968027,0.00010572587,0.0013239351,0.00064441346,0.00071622187,0.00040703794],"domain_scores_gemma":[0.9971939,0.00023535178,0.0008998403,0.0011334488,0.000378905,0.00015859281],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024927198,0.0005390452,0.0030028825,0.00013811761,0.000034576482,0.000003718506,0.000349244,0.00055623916,0.0007558373],"category_scores_gemma":[0.00008489805,0.00039267648,0.0005950977,0.00015125712,0.00022644129,0.000021831007,0.00023701006,0.00011818143,0.00012808178],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009439064,0.0016525132,0.000032570053,0.050966598,0.0006987019,0.0005574049,0.00009193876,2.5081835e-8,0.0000055515834,0.00014803694,0.9388406,0.0069116647],"study_design_scores_gemma":[0.004184776,0.0007211823,0.000016136164,0.041282184,0.0010632229,0.00011245339,0.00006361762,0.0000017755199,0.0032807395,0.000011145817,0.9490035,0.00025922028],"about_ca_topic_score_codex":0.00020171938,"about_ca_topic_score_gemma":0.000012309356,"teacher_disagreement_score":0.11691878,"about_ca_system_score_codex":0.00023853999,"about_ca_system_score_gemma":0.0003667719,"threshold_uncertainty_score":0.99985254},"labels":[],"label_agreement":null},{"id":"W2907343172","doi":"10.1080/17474086.2018.1564032","title":"Switching patients in the age of long-acting recombinant products?","year":2019,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Impact","funders":"CSL Behring","keywords":"Medicine; Dosing; Regimen; Intensive care medicine; Expert opinion; Surgery; Pharmacology","score_opus":0.09632214904559563,"score_gpt":0.4310467430819854,"score_spread":0.33472459403638977,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2907343172","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0001030704,0.9939942,0.0000011658963,0.0005710561,0.00032714958,0.0038351314,0.0000021559108,0.0000075612975,0.0011585085],"genre_scores_gemma":[0.000078046105,0.9989275,0.00016586963,0.00016825761,0.00005622949,0.00018779024,0.00021118125,0.000038905775,0.00016627014],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9966347,0.00067022955,0.0015057153,0.00042468708,0.0004135182,0.00035111018],"domain_scores_gemma":[0.9976073,0.0005172465,0.00072131347,0.0009631372,0.00015276425,0.000038247465],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0010923531,0.00035281802,0.004533759,0.00023295375,0.000026867627,0.0000035411376,0.00039834433,0.00022636706,0.00007704531],"category_scores_gemma":[0.0012098663,0.00016986662,0.00057144254,0.00053484854,0.00007874919,0.00003691872,0.00012076673,0.0005532494,0.000058602804],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000059359754,0.0004122411,0.00051854167,0.4301798,0.000106691085,0.0001882717,0.0001829238,6.522773e-10,5.627967e-7,0.000059577927,0.0013564196,0.56698906],"study_design_scores_gemma":[0.0003327699,0.0002292043,0.000029799176,0.31917706,0.00029385803,0.0003710049,0.00002201885,1.19084476e-7,0.000014803532,0.0000037299176,0.67940986,0.00011577179],"about_ca_topic_score_codex":0.000040018007,"about_ca_topic_score_gemma":0.0000030705294,"teacher_disagreement_score":0.67805344,"about_ca_system_score_codex":0.00007438339,"about_ca_system_score_gemma":0.0003479581,"threshold_uncertainty_score":0.692696},"labels":[],"label_agreement":null},{"id":"W2930354013","doi":"10.1080/17474086.2019.1602036","title":"Humanistic burden of patients with chronic graft-versus-host disease - systematic literature review of health-related quality of life and functional status","year":2019,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Quality of life (healthcare); Graft-versus-host disease; Hematopoietic stem cell transplantation; Disease; Intensive care medicine; MEDLINE; Cohort; Physical therapy; Internal medicine","score_opus":0.045753115184816555,"score_gpt":0.35933121948348495,"score_spread":0.3135781042986684,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2930354013","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000036991896,0.9915975,0.000043750093,0.00012371011,0.00025885197,0.007452288,0.0004166873,0.000014597024,0.000055626235],"genre_scores_gemma":[0.00028604866,0.99655765,0.00017163738,0.00013146487,0.000023223114,0.0002556465,0.002488626,0.00006053885,0.0000251475],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99057466,0.0017051976,0.0059818127,0.00055514777,0.0008530671,0.00033010033],"domain_scores_gemma":[0.9903612,0.0012028024,0.0062912526,0.0010811752,0.00079819246,0.00026534084],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0013091606,0.0005971677,0.0120787565,0.0002407181,0.00002912798,0.0000027499484,0.00017271313,0.00027002543,0.00031083645],"category_scores_gemma":[0.0013010944,0.00038742909,0.00073641224,0.0005553862,0.00028648908,0.000059174174,0.000051487044,0.00032362866,0.0000100996995],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015241197,0.0002032126,0.0001366144,0.99556315,0.0008678225,0.0000072309704,0.00014559548,3.7776665e-8,4.4763246e-7,0.0011480442,0.00037936913,0.0013960382],"study_design_scores_gemma":[0.0017694491,0.00057909806,0.00019071515,0.9824403,0.0034325302,0.00007877511,0.000014642805,8.5603256e-7,7.2492884e-7,0.0000024758829,0.011246431,0.00024401693],"about_ca_topic_score_codex":0.000029512961,"about_ca_topic_score_gemma":0.0000019977479,"teacher_disagreement_score":0.01312289,"about_ca_system_score_codex":0.00014563254,"about_ca_system_score_gemma":0.0018184037,"threshold_uncertainty_score":0.9998578},"labels":[],"label_agreement":null},{"id":"W2931542173","doi":"10.1080/17474086.2019.1605288","title":"A systematic literature review of incidence, mortality, and relapse of patients diagnosed with chronic graft versus host disease","year":2019,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Graft-versus-host disease; Disease; Incidence (geometry); Hematopoietic stem cell transplantation; Cohort; Transplantation; Internal medicine; Mortality rate; Intensive care medicine","score_opus":0.028515375590845115,"score_gpt":0.3590130971644008,"score_spread":0.33049772157355567,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2931542173","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000061114275,0.9900013,0.000010736594,0.00005071122,0.00025020973,0.0093298135,0.0001608474,0.000016788534,0.00011845266],"genre_scores_gemma":[0.00007616096,0.9978299,0.00022353964,0.00019038102,0.000029577443,0.0007677243,0.0007912981,0.00007118191,0.000020236124],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99418324,0.0008033313,0.0033273078,0.00061687094,0.0007762099,0.000293022],"domain_scores_gemma":[0.9934716,0.0012141436,0.0030443855,0.0014530723,0.0005929147,0.00022385812],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000707921,0.0006763835,0.01005401,0.0002544742,0.00001891905,0.0000043115356,0.0003207103,0.00030926982,0.000095370226],"category_scores_gemma":[0.0013016202,0.0004176209,0.0008116249,0.00071898836,0.0002560962,0.00008742402,0.00008263412,0.0003322595,0.000016303795],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053746022,0.0002028626,0.0003637945,0.9961203,0.000706196,0.00019123394,0.000094147115,2.928612e-9,3.0072107e-7,0.00028770955,0.0004912599,0.0014884861],"study_design_scores_gemma":[0.0013014642,0.0005548334,0.00007817471,0.9701346,0.01089366,0.0004462755,0.0000062501076,4.800196e-7,0.000004901262,0.000001229576,0.016284922,0.0002932066],"about_ca_topic_score_codex":0.00001006943,"about_ca_topic_score_gemma":0.000004233768,"teacher_disagreement_score":0.025985656,"about_ca_system_score_codex":0.00010138968,"about_ca_system_score_gemma":0.0008286068,"threshold_uncertainty_score":0.99982756},"labels":[],"label_agreement":null},{"id":"W2955990262","doi":"10.1080/17474086.2019.1636645","title":"High-dose intravenous immunoglobulin for the treatment and prevention of heparin-induced thrombocytopenia: a review","year":2019,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":173,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Regional Laboratory Medicine Program; Hamilton Health Sciences; Hamilton General Hospital","funders":"","keywords":"Medicine; Heparin-induced thrombocytopenia; Heparin; Fondaparinux; Antibody; Platelet; Thrombosis; Immunology; Refractory (planetary science); Platelet activation; Platelet factor 4; Internal medicine; Venous thromboembolism","score_opus":0.09428233042341318,"score_gpt":0.4167660414438062,"score_spread":0.322483711020393,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2955990262","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000063805055,0.982111,0.000036988058,0.0009768418,0.0005777373,0.015947366,0.000055938966,0.00003161368,0.00019870469],"genre_scores_gemma":[0.000068503985,0.9947739,0.0013978577,0.0006019935,0.00013603932,0.002387084,0.0003106129,0.00011997409,0.00020400464],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9946492,0.00057820225,0.003032009,0.00089923706,0.00029540688,0.0005459493],"domain_scores_gemma":[0.99436504,0.001087205,0.0020996996,0.0019725738,0.00032001283,0.00015548608],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009693009,0.00097261375,0.014002692,0.00016236323,0.00010398168,0.000010249034,0.0005434564,0.0005566825,0.00033638833],"category_scores_gemma":[0.0004350225,0.0005537981,0.0021136263,0.00045373384,0.00023363066,0.0000757722,0.00019283213,0.00039857224,0.00006709352],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000027681052,0.0003958502,0.000001328205,0.41496724,0.0016298962,0.000006983694,0.000052938387,3.133351e-9,0.000033672008,0.0014707975,0.0012821028,0.58013153],"study_design_scores_gemma":[0.0010029972,0.0017523245,0.000009392222,0.35375336,0.009022277,0.0009943016,0.000010378297,4.1650355e-7,0.00019218557,0.000031307696,0.63292927,0.0003017937],"about_ca_topic_score_codex":0.00018903312,"about_ca_topic_score_gemma":0.000015554451,"teacher_disagreement_score":0.63164717,"about_ca_system_score_codex":0.00024766705,"about_ca_system_score_gemma":0.0011030218,"threshold_uncertainty_score":0.99969137},"labels":[],"label_agreement":null},{"id":"W2968803688","doi":"10.1080/17474086.2019.1657824","title":"Platelet and red cell transfusions for neonates: lifesavers or Trojan horses?","year":2019,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Blood transfusion and management","field":"Medicine","cited_by":26,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; University Health Network","funders":"","keywords":"Medicine; Platelet; Red Cell; Platelet transfusion; Intensive care medicine; Internal medicine","score_opus":0.05839979609643514,"score_gpt":0.38351045092977504,"score_spread":0.3251106548333399,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W2968803688","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000010182965,0.9880788,0.00018343538,0.0016609252,0.00045947093,0.0076585882,0.00005791573,0.000049869148,0.0018500321],"genre_scores_gemma":[0.0000011541372,0.9920787,0.0025408813,0.0025112557,0.00007460692,0.00083171966,0.00020175742,0.000088262364,0.0016716269],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9972098,0.00016472701,0.0013631003,0.00066523225,0.00021292015,0.00038422275],"domain_scores_gemma":[0.998149,0.00041684942,0.00042546418,0.00071501883,0.00009361724,0.00020006487],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003306951,0.00056329515,0.0056159236,0.00024610493,0.000057077184,0.000005466461,0.00023356744,0.0004265775,0.00082048454],"category_scores_gemma":[0.0001312259,0.0003536062,0.0010421461,0.00026262473,0.00011170746,0.00003406315,0.00006095432,0.00030899094,0.000043659213],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000053326054,0.00015641616,2.0922047e-7,0.4702517,0.000264868,0.000047977534,0.000067198154,2.387019e-9,0.0000019379086,0.0004348582,0.049793355,0.47892815],"study_design_scores_gemma":[0.0015668467,0.00046150145,1.0288275e-7,0.14384359,0.0023383214,0.0007947305,0.000050427017,0.0000010979466,0.000020576073,0.000005357663,0.85064816,0.00026929384],"about_ca_topic_score_codex":0.0000118528205,"about_ca_topic_score_gemma":0.000006442447,"teacher_disagreement_score":0.8008548,"about_ca_system_score_codex":0.000030458974,"about_ca_system_score_gemma":0.0003183319,"threshold_uncertainty_score":0.9998916},"labels":[],"label_agreement":null},{"id":"W3082023690","doi":"10.1080/17474086.2020.1818065","title":"Patient-reported symptom burden of chronic graft versus host disease: a systematic literature review","year":2020,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Hematopoietic Stem Cell Transplantation","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Quality of life (healthcare); MEDLINE; Graft-versus-host disease; Systematic review; Intensive care medicine; Hematopoietic stem cell transplantation; Generalizability theory; Disease; Randomized controlled trial; Clinical trial; Transplantation; Internal medicine","score_opus":0.02380648728980961,"score_gpt":0.3477728820044329,"score_spread":0.3239663947146233,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3082023690","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[2.5283975e-7,0.98723704,0.000036520014,0.0007521219,0.0006436796,0.010772854,0.000114742135,0.00007985312,0.00036296865],"genre_scores_gemma":[0.0000034013997,0.9959507,0.00030379748,0.00047267022,0.00016510962,0.0015836814,0.001343278,0.00013152967,0.00004581857],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99130327,0.0010707112,0.0053573237,0.00090334314,0.0009099055,0.00045545248],"domain_scores_gemma":[0.99252856,0.0008706291,0.0038145934,0.0018320135,0.00051471975,0.00043949686],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00052055594,0.0009969102,0.0140370475,0.00026770987,0.000034650304,0.0000082308325,0.00044934932,0.00045949675,0.00040265342],"category_scores_gemma":[0.0017287282,0.00068817707,0.002295053,0.001255415,0.00017146363,0.000069014575,0.000102824706,0.0005704892,0.00012428017],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000034424233,0.00011570955,5.576541e-7,0.9720051,0.0013381302,0.0014933511,0.00019184277,5.5344778e-9,0.0000026137632,0.0002922672,0.004563856,0.01996211],"study_design_scores_gemma":[0.00041726977,0.00022186988,8.932333e-8,0.5883263,0.009266061,0.003307464,0.000008621582,0.0000015010074,0.0000061872574,7.3728785e-7,0.39818177,0.0002621715],"about_ca_topic_score_codex":0.000004237635,"about_ca_topic_score_gemma":4.208881e-7,"teacher_disagreement_score":0.39361793,"about_ca_system_score_codex":0.00021906124,"about_ca_system_score_gemma":0.0013898475,"threshold_uncertainty_score":0.99955696},"labels":[],"label_agreement":null},{"id":"W3109921710","doi":"10.1080/17474086.2021.1860002","title":"Evidence-based indications of platelet-rich plasma therapy","year":2020,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Periodontal Regeneration and Treatments","field":"Medicine","cited_by":181,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; Queen's University","funders":"","keywords":"Medicine; Intensive care medicine; Platelet; Internal medicine","score_opus":0.1263385500403964,"score_gpt":0.4214560583552552,"score_spread":0.2951175083148588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3109921710","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000015819181,0.9962568,0.000026175338,0.0013731901,0.00015668462,0.00179312,0.000023576149,0.000027828799,0.000326806],"genre_scores_gemma":[0.000047226546,0.99635935,0.0013036045,0.001301752,0.000053187814,0.00050848216,0.00029399048,0.00003953065,0.000092872004],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99753976,0.0002712073,0.001340331,0.00038057152,0.0002961449,0.00017197238],"domain_scores_gemma":[0.9977961,0.0003305178,0.0009909477,0.00060137647,0.00014005521,0.00014101322],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0001424922,0.0003813504,0.0042884503,0.00018019714,0.000032138178,0.0000029805599,0.000235776,0.0002696982,0.0008353005],"category_scores_gemma":[0.00050280825,0.00024762313,0.0007684985,0.00047293692,0.00014211463,0.000040951443,0.000036238176,0.00020856143,0.00013345909],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000018260758,0.0002835951,0.00002165146,0.12370358,0.00048450855,0.00006595867,0.00004362183,7.805098e-9,0.000010065615,0.00056732603,0.005708941,0.86909246],"study_design_scores_gemma":[0.00038455738,0.0002571125,0.0000032467865,0.2093784,0.00033772815,0.00044025117,0.0000025159807,8.8533227e-7,0.0007760114,0.0000012752781,0.78829974,0.00011830197],"about_ca_topic_score_codex":0.000007799688,"about_ca_topic_score_gemma":0.000001138745,"teacher_disagreement_score":0.8689742,"about_ca_system_score_codex":0.00007366848,"about_ca_system_score_gemma":0.001124449,"threshold_uncertainty_score":0.9999976},"labels":[],"label_agreement":null},{"id":"W3125119901","doi":"10.1080/17474086.2021.1875817","title":"Key questions in the new hemophilia era: update on concomitant use of FVIII and emicizumab in hemophilia A patients with inhibitors","year":2021,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Institute for Clinical Evaluative Sciences; SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Medicine; Bispecific antibody; Concomitant; Expert opinion; Immunology; Monoclonal antibody; Intensive care medicine; Antibody; Internal medicine","score_opus":0.03813247909115668,"score_gpt":0.36375848524961635,"score_spread":0.32562600615845966,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W3125119901","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0021286004,0.9915324,8.0455277e-7,0.002878515,0.00010285752,0.003193147,0.000031402684,0.00000955034,0.0001227416],"genre_scores_gemma":[0.00045152966,0.9976731,0.00050547125,0.00062547706,0.000051934854,0.00022372208,0.00031530656,0.00005080108,0.00010263773],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99588066,0.000856522,0.0016855678,0.0006176046,0.0005378112,0.00042183918],"domain_scores_gemma":[0.9973546,0.0008400575,0.000539409,0.0009201759,0.00018838255,0.0001573193],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000474838,0.00056485063,0.004838224,0.00046097537,0.000036046833,0.000010626032,0.00025631956,0.00036369028,0.000092119284],"category_scores_gemma":[0.0008119415,0.00029523962,0.00039120886,0.0009526973,0.00030939074,0.00007276124,0.00012765074,0.00080991833,0.000015287884],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00033496233,0.0036734317,0.00683336,0.26553252,0.00084078556,0.0022430774,0.0011723934,1.7399552e-7,0.0000026170242,0.006785998,0.036241673,0.67633903],"study_design_scores_gemma":[0.0019094794,0.00052663917,0.00014335495,0.35191572,0.00038583676,0.0005972035,0.00003118422,8.3515323e-7,0.000015781512,0.000025105537,0.6441787,0.00027017863],"about_ca_topic_score_codex":0.00012423853,"about_ca_topic_score_gemma":0.000055936864,"teacher_disagreement_score":0.67606884,"about_ca_system_score_codex":0.00015729255,"about_ca_system_score_gemma":0.0009091499,"threshold_uncertainty_score":0.99995},"labels":[],"label_agreement":null},{"id":"W4324308734","doi":"10.1080/17474086.2023.2175661","title":"Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities for ultra-rare inherited bleeding disorders","year":2023,"lang":"en","type":"article","venue":"Expert Review of Hematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":17,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Hamilton Health Sciences; Hamilton Regional Laboratory Medicine Program","funders":"National Heart, Lung, and Blood Institute","keywords":"Medicine; Blueprint; Psychosocial; Multidisciplinary approach; Distress; Intensive care medicine; Psychiatry","score_opus":0.2303191520935952,"score_gpt":0.5041977961139616,"score_spread":0.27387864402036644,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324308734","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.594335,0.121989965,0.0067853606,0.22595394,0.0011701129,0.04652547,0.00025167537,0.00059150916,0.0023969437],"genre_scores_gemma":[0.8550987,0.106783666,0.014322897,0.0006795458,0.00077506574,0.01986597,0.0014234781,0.00020871265,0.0008419097],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9954945,0.0010134918,0.00084669824,0.00046661135,0.0011691665,0.0010095355],"domain_scores_gemma":[0.98642236,0.00934716,0.00015066804,0.00048155058,0.0034689605,0.00012931606],"candidate_categories":["metaresearch","sts"],"consensus_categories":[],"category_scores_codex":[0.012833663,0.00025691834,0.00082902383,0.0008122396,0.0017536002,0.0000661431,0.00050747837,0.00023140459,0.000051816165],"category_scores_gemma":[0.014188551,0.0001840104,0.00032235312,0.0019911996,0.00068259356,0.0001541104,0.00019600634,0.000771863,0.000011330036],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0048112427,0.0027540198,0.008604786,0.15960114,0.0028150603,0.000014482006,0.02178816,0.000022915861,0.21398008,0.16324985,0.2601731,0.16218516],"study_design_scores_gemma":[0.013464781,0.0060594412,0.0010797497,0.035646655,0.00024059041,0.00014499693,0.031089786,0.015550773,0.050342143,0.067017585,0.77828085,0.0010826185],"about_ca_topic_score_codex":0.00016562264,"about_ca_topic_score_gemma":0.00012102295,"teacher_disagreement_score":0.5181078,"about_ca_system_score_codex":0.0003281755,"about_ca_system_score_gemma":0.0006490541,"threshold_uncertainty_score":0.999546},"labels":[],"label_agreement":null},{"id":"W4324311216","doi":"10.1080/17474086.2023.2181781","title":"Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: facilitating research through infrastructure, workforce, resources and funding","year":2023,"lang":"en","type":"article","venue":"Expert Review of Hematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":12,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Hemophilia Society","funders":"National Hemophilia Foundation","keywords":"Blueprint; Medicine; Workforce; Multidisciplinary approach; Summit; Capacity building; Workforce development; Medical education; Public relations; Nursing; Political science; Engineering","score_opus":0.26615155739254037,"score_gpt":0.5173313830945768,"score_spread":0.25117982570203645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324311216","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.88867635,0.07325736,0.0023421948,0.026111448,0.00016111071,0.0074189724,0.00002749512,0.00012048834,0.0018846107],"genre_scores_gemma":[0.9009084,0.06137694,0.03258149,0.00048751794,0.00036246856,0.0034867171,0.00033033904,0.00007796564,0.00038816975],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99650085,0.0010981861,0.0005626247,0.00031666728,0.0008848097,0.0006368748],"domain_scores_gemma":[0.98926437,0.008603601,0.00010263623,0.000312576,0.0016399528,0.00007685164],"candidate_categories":["metaresearch","sts"],"consensus_categories":[],"category_scores_codex":[0.011690012,0.0001544,0.0005269483,0.00041497353,0.001441819,0.00004633827,0.00025913195,0.00013420238,0.000029340368],"category_scores_gemma":[0.012441443,0.00010158524,0.00011606557,0.0015120847,0.0006248229,0.00010866967,0.0002915122,0.00067959336,0.0000057710527],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.002359387,0.0007982803,0.015736783,0.09234555,0.0014844742,0.000018958228,0.069011435,0.000049504153,0.078221574,0.27400053,0.13850965,0.3274639],"study_design_scores_gemma":[0.0062334626,0.0029062447,0.0021088931,0.03397092,0.00010088362,0.000229301,0.04780042,0.015426167,0.013057246,0.15359752,0.7239583,0.0006106512],"about_ca_topic_score_codex":0.00008156272,"about_ca_topic_score_gemma":0.00001706795,"teacher_disagreement_score":0.5854487,"about_ca_system_score_codex":0.00016662217,"about_ca_system_score_gemma":0.00020326063,"threshold_uncertainty_score":0.99985814},"labels":[],"label_agreement":null},{"id":"W4324311538","doi":"10.1080/17474086.2023.2183836","title":"Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities in health services; diversity, equity, and inclusion; and implementation science","year":2023,"lang":"en","type":"article","venue":"Expert Review of Hematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":23,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"National Institutes of Health; Health Resources and Services Administration; National Hemophilia Foundation","keywords":"Blueprint; Medicine; Inclusion (mineral); Stakeholder; Health care; Equity (law); Public relations; Workforce; Nursing; Health services research; Diversity (politics); Health equity; Public health; Political science; Sociology","score_opus":0.2813170922981152,"score_gpt":0.5870100944442785,"score_spread":0.30569300214616335,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4324311538","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.90019405,0.022314753,0.00007305085,0.07266261,0.000048465576,0.0045688734,0.000010775436,0.000021815733,0.00010563435],"genre_scores_gemma":[0.9486689,0.04881504,0.0015497317,0.00043184188,0.000032238593,0.0004171182,0.000064489905,0.000008888267,0.000011763645],"study_design_codex":"design_other","study_design_gemma":"theoretical_or_conceptual","domain_scores_codex":[0.99727076,0.0006035583,0.00035754772,0.00022597711,0.0011088676,0.00043328124],"domain_scores_gemma":[0.9968215,0.001701266,0.00007046339,0.00015464019,0.00117741,0.00007468938],"candidate_categories":["sts","open_science"],"consensus_categories":[],"category_scores_codex":[0.026205055,0.000076158874,0.00029789016,0.00064351474,0.003845979,0.00003568941,0.00029277636,0.000042665462,0.000008366069],"category_scores_gemma":[0.0010530421,0.000054478223,0.000027306996,0.0013490191,0.0006157479,0.00013537715,0.010707774,0.00026247653,6.750165e-7],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009071961,0.0008350034,0.061234973,0.15284713,0.00019528857,0.000007965719,0.121198975,0.000002049276,0.04661374,0.18600266,0.00492637,0.42522866],"study_design_scores_gemma":[0.022525012,0.00913561,0.059418682,0.06547445,0.00007404356,0.00027350368,0.13815995,0.025519714,0.024505189,0.597536,0.05649319,0.0008846559],"about_ca_topic_score_codex":0.0014890225,"about_ca_topic_score_gemma":0.00078982743,"teacher_disagreement_score":0.424344,"about_ca_system_score_codex":0.0002853658,"about_ca_system_score_gemma":0.0005571384,"threshold_uncertainty_score":0.9974509},"labels":[],"label_agreement":null},{"id":"W4327892775","doi":"10.1080/17474086.2023.2192474","title":"Applications of artificial intelligence in clinical management, research, and health administration: imaging perspectives with a focus on hemophilia","year":2023,"lang":"en","type":"article","venue":"Expert Review of Hematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hospital for Sick Children; University of Toronto","funders":"","keywords":"Medicine; Health care; Workforce; Intervention (counseling); Medical physics; Nursing","score_opus":0.14198181882217722,"score_gpt":0.5248402677431172,"score_spread":0.38285844892094,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4327892775","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.05887647,0.4612027,0.0020373855,0.44787955,0.0001074132,0.012399458,0.00001699145,0.00014580459,0.017334215],"genre_scores_gemma":[0.80375254,0.19315284,0.0022529499,0.00022017972,0.000053985077,0.0003786223,0.000016680526,0.0000135725595,0.00015858884],"study_design_codex":"design_other","study_design_gemma":"systematic_review","domain_scores_codex":[0.99837345,0.00017491422,0.00061925617,0.0003168491,0.00028247028,0.0002330567],"domain_scores_gemma":[0.9990715,0.00026157193,0.00010408531,0.0003247281,0.00014481062,0.00009330763],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0014657852,0.00008814649,0.00055554596,0.00031801744,0.000048548514,0.0000029756247,0.000088950284,0.000034822395,0.00003861473],"category_scores_gemma":[0.00010453022,0.000061291095,0.000050692244,0.00084520766,0.00049505336,0.000022805472,0.000056230074,0.00019711343,0.000021818463],"study_design_candidate":"design_other","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004850665,0.0020979876,0.019836992,0.013194179,0.00012617295,0.00040745002,0.0012314834,8.126475e-8,0.000029657593,0.3614006,0.0035325566,0.59765774],"study_design_scores_gemma":[0.012659497,0.06234781,0.14672662,0.27928227,0.0004252926,0.005809178,0.14684929,0.0024143797,0.03279139,0.22446711,0.083454594,0.0027725652],"about_ca_topic_score_codex":0.000021002304,"about_ca_topic_score_gemma":0.00002150079,"teacher_disagreement_score":0.7448761,"about_ca_system_score_codex":0.000036919977,"about_ca_system_score_gemma":0.0001667464,"threshold_uncertainty_score":0.24993782},"labels":[],"label_agreement":null},{"id":"W4377564037","doi":"10.1080/17474086.2023.2216930","title":"Strategies to overcome the diagnostic challenges of autoimmune hemolytic anemias","year":2023,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Blood groups and transfusion","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Health, British Columbia; Ministero della Salute","keywords":"Medicine; Autoimmune hemolytic anemia; Lymphoproliferative disorders; Immunology; Hematologic disorders; Diagnostic test; Intensive care medicine; Pediatrics; Antibody; Lymphoma","score_opus":0.06736388104555191,"score_gpt":0.3964508081188775,"score_spread":0.3290869270733256,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4377564037","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000004347167,0.9924945,0.00001280016,0.0035542832,0.0003410774,0.0025962263,0.000014704874,0.000056359953,0.00092566194],"genre_scores_gemma":[0.000037922928,0.9986201,0.00015198896,0.00043130122,0.000094182986,0.00047389657,0.0000440082,0.000079552075,0.00006703774],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.996928,0.00029131965,0.0016519303,0.00044706193,0.00034351347,0.00033820188],"domain_scores_gemma":[0.9960526,0.0020192699,0.00053663534,0.0011684109,0.0001270133,0.000096025804],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00058686506,0.00048375444,0.005749776,0.00018671184,0.00003972116,0.000004405648,0.00045425392,0.00033086285,0.00017256953],"category_scores_gemma":[0.00073284644,0.00026429904,0.00093930616,0.00051506347,0.00017832287,0.00003311475,0.0001550166,0.0004157104,0.00014556634],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000005472239,0.00015303682,8.3691936e-7,0.6091634,0.0003786625,0.00013391134,0.00030047575,2.554914e-8,0.0000020854961,0.015229732,0.0028053771,0.37182698],"study_design_scores_gemma":[0.00015954464,0.00023444254,0.000015592914,0.36108792,0.001088494,0.0010690223,0.00013273873,1.9167861e-7,0.0000069020853,0.00008343791,0.63596225,0.00015945721],"about_ca_topic_score_codex":0.00006279401,"about_ca_topic_score_gemma":0.000011720575,"teacher_disagreement_score":0.6331569,"about_ca_system_score_codex":0.00002994615,"about_ca_system_score_gemma":0.00038230245,"threshold_uncertainty_score":0.9999809},"labels":[],"label_agreement":null},{"id":"W4379509220","doi":"10.1080/17474086.2023.2221846","title":"Gastrointestinal bleeding in von Willebrand patients: special diagnostic and management considerations","year":2023,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":6,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Toronto; St. Michael's Hospital; Queen's University","funders":"","keywords":"Angiodysplasia; Medicine; Von Willebrand disease; Von Willebrand factor; Gastrointestinal bleeding; Intensive care medicine; Internal medicine; Platelet","score_opus":0.034934350646900494,"score_gpt":0.35381197757566213,"score_spread":0.31887762692876165,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4379509220","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000039125942,0.9959794,0.0000026073117,0.00022010019,0.00015691106,0.0022408576,0.000017447126,0.000019750216,0.0013237895],"genre_scores_gemma":[0.0000059762024,0.99813485,0.00086212734,0.0002361084,0.00008133013,0.0003805489,0.00021448314,0.000035212754,0.000049387938],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.9981137,0.00009730751,0.0010017679,0.00037504983,0.00015688028,0.00025528696],"domain_scores_gemma":[0.99863505,0.00069127895,0.00031741665,0.00022474844,0.00005204748,0.000079454374],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00013658081,0.00032761542,0.0029916612,0.00026658838,0.00003690655,0.0000063157713,0.00005550011,0.000075053424,0.0001745385],"category_scores_gemma":[0.0008407044,0.00024429226,0.00022171086,0.00023114268,0.00008881191,0.000034124387,0.00008895963,0.00017002814,0.000060002407],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000012064,0.0006781231,0.0019912336,0.6083019,0.0005115001,0.0071279514,0.00006432014,1.665873e-8,2.0544359e-8,0.0039480263,0.0346535,0.3427114],"study_design_scores_gemma":[0.0010543895,0.00017401727,0.00009158006,0.5204541,0.0007921355,0.0039452906,0.00001712093,4.8348596e-7,1.3757388e-7,0.00014267699,0.4731498,0.00017823212],"about_ca_topic_score_codex":0.000008953076,"about_ca_topic_score_gemma":0.000014763482,"teacher_disagreement_score":0.43849632,"about_ca_system_score_codex":0.000059326532,"about_ca_system_score_gemma":0.000071914816,"threshold_uncertainty_score":0.99619484},"labels":[],"label_agreement":null},{"id":"W4385827620","doi":"10.1080/17474086.2023.2243386","title":"Patient-centered care in von Willebrand disease: are we there yet?","year":2023,"lang":"en","type":"article","venue":"Expert Review of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Queen's University; St. Michael's Hospital","funders":"","keywords":"Medicine; Intensive care medicine; Disease; Von Willebrand disease; Pediatrics; Von Willebrand factor; Internal medicine; Platelet","score_opus":0.018628209518339694,"score_gpt":0.32024152614963536,"score_spread":0.30161331663129565,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4385827620","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.29614922,0.6970957,5.557319e-7,0.00540467,0.00012563444,0.0005760393,0.000021009495,0.000035141427,0.00059206696],"genre_scores_gemma":[0.64223826,0.3563157,0.000038626535,0.0010243171,0.000008954564,0.00011143907,0.00017167773,0.000018196646,0.000072860035],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9990272,0.00006197513,0.00034160595,0.00022246553,0.00013473615,0.00021201273],"domain_scores_gemma":[0.9994211,0.000039773196,0.00011385286,0.00029191392,0.000044769404,0.000088581146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00003373841,0.0001443145,0.0007673244,0.00008851935,0.000020730231,0.0000016592901,0.000059179427,0.00005482242,0.00020476937],"category_scores_gemma":[0.000083277904,0.00010254332,0.00013489446,0.00023276455,0.000040399194,0.000028285363,0.00003958882,0.00006697534,0.000084591295],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00089919963,0.0017481574,0.55489933,0.074921496,0.00047801484,0.019463025,0.005099184,8.891036e-7,0.00012818802,0.0008423844,0.19173667,0.14978348],"study_design_scores_gemma":[0.011887988,0.0009829022,0.04519499,0.1598747,0.00030869656,0.0008085352,0.0064207246,0.000052690197,0.0013578999,0.000588304,0.7717608,0.00076174503],"about_ca_topic_score_codex":0.000011907046,"about_ca_topic_score_gemma":0.00002126236,"teacher_disagreement_score":0.5800242,"about_ca_system_score_codex":0.00002699706,"about_ca_system_score_gemma":0.000043755776,"threshold_uncertainty_score":0.41815954},"labels":[],"label_agreement":null},{"id":"W4387540453","doi":"10.1080/17474086.2023.2268273","title":"Immunotherapy for myelodysplastic syndrome and acute myeloid leukemia: where do we stand?","year":2023,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"CAR-T cell therapy research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McGill University; Jewish General Hospital","funders":"","keywords":"Medicine; Chimeric antigen receptor; Immunotherapy; Myeloid leukemia; Clinical trial; Immunology; Myelodysplastic syndromes; Myeloid; Tolerability; T cell; Immune system; Oncology; Cancer research; Internal medicine; Bone marrow; Adverse effect","score_opus":0.049156869697557774,"score_gpt":0.40672588013009886,"score_spread":0.3575690104325411,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4387540453","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000029372868,0.9920814,0.000084378786,0.000960588,0.0004321348,0.006003167,0.00012470275,0.00010383528,0.00020687509],"genre_scores_gemma":[1.2106699e-7,0.9905296,0.00088695926,0.00016394329,0.00016327064,0.0021335906,0.00010003373,0.000290968,0.005731514],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99549097,0.00036329802,0.0019239807,0.00093348435,0.0005222914,0.0007659964],"domain_scores_gemma":[0.99588,0.0016534402,0.00072893297,0.0012453918,0.0002492764,0.00024294246],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.0009519992,0.00083085976,0.008552325,0.00045083085,0.000090788715,0.000021430867,0.000498021,0.00073865394,0.0020374765],"category_scores_gemma":[0.0003012828,0.0005915954,0.0013258228,0.00066126016,0.00036093572,0.00005639731,0.00020094267,0.00075758796,0.00015007594],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00007092124,0.000037272457,5.4743504e-7,0.44213375,0.0015431227,0.00032984267,0.0000535449,2.7803861e-9,0.000024841478,0.00034643873,0.017502638,0.5379571],"study_design_scores_gemma":[0.00079759397,0.00052254525,2.3798954e-7,0.3118623,0.0008005202,0.009463752,0.00001790515,0.000001041804,0.000007834761,0.000052663418,0.676176,0.00029763175],"about_ca_topic_score_codex":0.000010631736,"about_ca_topic_score_gemma":0.0000026785244,"teacher_disagreement_score":0.65867335,"about_ca_system_score_codex":0.00037545888,"about_ca_system_score_gemma":0.0013858941,"threshold_uncertainty_score":0.9996535},"labels":[],"label_agreement":null},{"id":"W4390273452","doi":"10.1080/17474086.2023.2298333","title":"Hematology in the post-COVID era: spotlight on vaccine-induced immune thrombotic thrombocytopenia and a conceptual framework (the 4P’s) for anti-PF4 diseases","year":2023,"lang":"en","type":"article","venue":"Expert Review of Hematology","topic":"Heparin-Induced Thrombocytopenia and Thrombosis","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University","funders":"Public Health Agency of Canada; Heart and Stroke Foundation of Canada","keywords":"Medicine; Hematology; Immune system; Immunology; Thrombosis; Platelet; Immune thrombocytopenia; Coronavirus disease 2019 (COVID-19); Antibody; Internal medicine; Disease; Infectious disease (medical specialty)","score_opus":0.03911822036750513,"score_gpt":0.36685744330676123,"score_spread":0.3277392229392561,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4390273452","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.811107,0.096377805,0.000047374677,0.086749494,0.0006216464,0.0045771035,0.000030828018,0.00014355789,0.00034521066],"genre_scores_gemma":[0.950873,0.030763103,0.00034301804,0.016921435,0.00014327478,0.0007705958,0.00009908464,0.000072332914,0.000014113223],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"observational","domain_scores_codex":[0.9960472,0.0006406936,0.0013362714,0.0007884932,0.00037869913,0.0008086684],"domain_scores_gemma":[0.9947249,0.003121974,0.00041584796,0.0013616033,0.00019009251,0.000185561],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0009354823,0.0005475186,0.0031663666,0.00023954277,0.00028532074,0.000023793398,0.00068695616,0.0003597147,0.00027669282],"category_scores_gemma":[0.002581221,0.00031163578,0.00045887168,0.00096390356,0.0004211842,0.00011312081,0.00022801217,0.0006452186,0.00015677688],"study_design_candidate":"theoretical_or_conceptual","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0013504716,0.003407646,0.043905985,0.028476208,0.002176876,0.0014547355,0.020614568,0.0000023186426,0.039399825,0.8147857,0.036865853,0.007559782],"study_design_scores_gemma":[0.021499766,0.0101087475,0.7246114,0.05865155,0.0035627715,0.011570121,0.019395607,0.0002879376,0.05777808,0.01678811,0.07201172,0.0037341728],"about_ca_topic_score_codex":0.000097415235,"about_ca_topic_score_gemma":0.00003349274,"teacher_disagreement_score":0.7979976,"about_ca_system_score_codex":0.00006224107,"about_ca_system_score_gemma":0.00028718478,"threshold_uncertainty_score":0.9999336},"labels":[],"label_agreement":null},{"id":"W4396773874","doi":"10.1080/17474086.2024.2353761","title":"How clinicians and persons with hemophilia may approach shared decision-making","year":2024,"lang":"en","type":"editorial","venue":"Expert Review of Hematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":9,"is_retracted":false,"has_abstract":false,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Hemophilia Society","funders":"","keywords":"Medicine; Intensive care medicine; Clinical decision making","score_opus":0.02905904599143895,"score_gpt":0.3868677625577894,"score_spread":0.35780871656635044,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396773874","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00007882845,0.8613833,0.000107787964,0.009770038,0.12310211,0.0018985369,0.00013287828,0.00008875243,0.003437717],"genre_scores_gemma":[0.0014054318,0.62032163,0.0276482,0.00080547517,0.33783227,0.0007006861,0.0010869801,0.00032684428,0.009872487],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965853,0.0001532783,0.00070857216,0.0010038617,0.0010327655,0.0005162359],"domain_scores_gemma":[0.99672353,0.0015965316,0.00027435334,0.00084654,0.00034382212,0.00021521981],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0005563218,0.00057093974,0.002812206,0.00031139184,0.00008416461,0.00004953137,0.00029001696,0.0009291645,0.00015348148],"category_scores_gemma":[0.0020666723,0.00033523614,0.00040913848,0.00036482446,0.00041468078,0.000066722285,0.000213596,0.0011601449,0.00003628048],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00017885289,0.000178351,0.00007596569,0.04183174,0.00047621696,0.0008670941,0.00025383764,5.639059e-9,0.0000040629866,0.00011757218,0.9438892,0.012127106],"study_design_scores_gemma":[0.0007773096,0.0006030625,0.000003358294,0.08634933,0.00051201874,0.0010112855,0.0002213584,0.000016426318,0.000015189433,0.000055284425,0.9101457,0.00028968704],"about_ca_topic_score_codex":0.000009200881,"about_ca_topic_score_gemma":0.000005246988,"teacher_disagreement_score":0.24106173,"about_ca_system_score_codex":0.00009608048,"about_ca_system_score_gemma":0.0007245611,"threshold_uncertainty_score":0.99990994},"labels":[],"label_agreement":null},{"id":"W4396774129","doi":"10.1080/17474086.2024.2353772","title":"Advances in our understanding of genetic markers and targeted therapies for pediatric LCH","year":2024,"lang":"en","type":"article","venue":"Expert Review of Hematology","topic":"Histiocytic Disorders and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"SickKids Foundation; Hospital for Sick Children; University of Toronto","funders":"","keywords":"Langerhans cell histiocytosis; Medicine; Histiocytosis; Myeloid; Targeted therapy; Pathology; Immunology; Disease; Internal medicine; Cancer","score_opus":0.021521335484386287,"score_gpt":0.3501035856866171,"score_spread":0.3285822502022308,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396774129","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.009050732,0.9877874,0.0010454486,0.0010860735,0.00010520941,0.00047138255,0.0000037542052,0.000008764074,0.00044118738],"genre_scores_gemma":[0.5090248,0.4884475,0.0023441187,0.00008948596,0.000011862779,0.00004784301,0.0000049737755,0.000007898948,0.00002153587],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99938524,0.000023484368,0.0002944363,0.0001366291,0.000060490675,0.00009973065],"domain_scores_gemma":[0.99973124,0.00008626145,0.000056345107,0.00008367767,0.00001897523,0.000023476414],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000087581466,0.000080880505,0.00046609048,0.00010159671,0.000011040182,0.0000013482379,0.00002591993,0.00003408459,0.00002693252],"category_scores_gemma":[0.00006749042,0.00005741269,0.00006405287,0.00013708754,0.00003243025,0.000026512073,0.000008166073,0.00002893696,9.785834e-7],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0007781041,0.0012576842,0.22051705,0.44571322,0.0008574162,0.00051298673,0.0062286155,0.0000017330945,0.0003963172,0.07133292,0.035239823,0.21716413],"study_design_scores_gemma":[0.04072195,0.013138445,0.031214481,0.23442611,0.0054763323,0.004528524,0.04250729,0.0037945635,0.0030308033,0.07548395,0.54242367,0.003253886],"about_ca_topic_score_codex":0.000006272526,"about_ca_topic_score_gemma":0.0000046374007,"teacher_disagreement_score":0.50718385,"about_ca_system_score_codex":0.000026792302,"about_ca_system_score_gemma":0.000052505053,"threshold_uncertainty_score":0.23412216},"labels":[],"label_agreement":null},{"id":"W4396921310","doi":"10.1080/17474086.2024.2356258","title":"The potential of triplet combination therapies for patients with FLT3-ITD -mutated acute myeloid leukemia","year":2024,"lang":"en","type":"article","venue":"Expert Review of Hematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Health, British Columbia","keywords":"Medicine; Myeloid leukemia; Myeloid; Leukemia; Cancer research; Oncology; Immunology","score_opus":0.010201312912358627,"score_gpt":0.3202986969299171,"score_spread":0.31009738401755843,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4396921310","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.22871915,0.7328547,0.0034920962,0.025952637,0.0009876308,0.007094074,0.0001010903,0.00016015462,0.00063846295],"genre_scores_gemma":[0.7400565,0.2520307,0.0041561024,0.0013197695,0.00012297848,0.00084116246,0.00059895404,0.00011538832,0.0007583992],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99825543,0.00013996912,0.000647001,0.00027147454,0.0003918666,0.00029424785],"domain_scores_gemma":[0.998361,0.00041811774,0.00019484595,0.00040592437,0.0005585203,0.000061619234],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00046008296,0.00018856947,0.0008077575,0.00011893835,0.00008041742,0.000010958685,0.00022635108,0.00010501102,0.00009473406],"category_scores_gemma":[0.0002634799,0.000100073674,0.00020533832,0.00034134593,0.00026452783,0.00007536756,0.000056597193,0.0001968356,0.000011615986],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.008183729,0.0014176955,0.0029218476,0.078222595,0.0087692775,0.00033478573,0.0029916898,0.0000017056217,0.025767013,0.05681704,0.506587,0.30798557],"study_design_scores_gemma":[0.033046283,0.014265925,0.007260002,0.054611307,0.0026734092,0.002187854,0.0012220886,0.0052034976,0.09036744,0.00369358,0.7840866,0.0013820393],"about_ca_topic_score_codex":0.000017985556,"about_ca_topic_score_gemma":0.000001980123,"teacher_disagreement_score":0.5113374,"about_ca_system_score_codex":0.00016556612,"about_ca_system_score_gemma":0.00047541747,"threshold_uncertainty_score":0.4080886},"labels":[],"label_agreement":null},{"id":"W4399687038","doi":"10.1080/17474086.2024.2366540","title":"The evolving management algorithm for the patient with newly diagnosed cold agglutinin disease","year":2024,"lang":"en","type":"article","venue":"Expert Review of Hematology","topic":"Blood groups and transfusion","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Health, British Columbia","keywords":"Medicine; Cold agglutinin disease; Algorithm; Disease management; Intensive care medicine; Disease; Immunology; Internal medicine; Parkinson's disease; Antibody; Computer science","score_opus":0.00941058982169735,"score_gpt":0.28811738173345014,"score_spread":0.2787067919117528,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4399687038","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0003464516,0.96416414,0.012112214,0.02001252,0.0003673826,0.002522808,0.000008344589,0.000041697538,0.00042442765],"genre_scores_gemma":[0.09599339,0.8694252,0.020114208,0.009942478,0.00025802368,0.0036511994,0.000038729406,0.000083744286,0.00049304054],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99901867,0.000044522574,0.00032536057,0.00021933728,0.00019166956,0.00020044937],"domain_scores_gemma":[0.9988856,0.0005334623,0.000059146736,0.0003819788,0.00006635171,0.00007350371],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00022424586,0.00013291983,0.0003474987,0.000024459221,0.00013207902,0.000012895962,0.00011268916,0.000026097963,0.000050745242],"category_scores_gemma":[0.00004574246,0.000054965418,0.00016704721,0.0001427157,0.00009743105,0.000025190275,0.000036377674,0.00008989234,0.0000075740973],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00009739919,0.00023257796,0.000100563535,0.0131506,0.00053444307,0.00066420826,0.0003629782,3.771875e-7,0.000020754715,0.030521533,0.08378048,0.87053406],"study_design_scores_gemma":[0.0010997402,0.00044601609,0.00023858638,0.022296326,0.00072004367,0.0002218095,0.00031416595,0.0023927686,0.00036909484,0.00010779595,0.9716607,0.00013297626],"about_ca_topic_score_codex":0.000012935059,"about_ca_topic_score_gemma":0.000004721253,"teacher_disagreement_score":0.8878802,"about_ca_system_score_codex":0.00001510756,"about_ca_system_score_gemma":0.000049357262,"threshold_uncertainty_score":0.22414246},"labels":[],"label_agreement":null},{"id":"W4400005506","doi":"10.1080/17474086.2024.2372325","title":"Optimizing salvage therapy for Hodgkin lymphoma: progress and future challenges","year":2024,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre; University of Toronto","funders":"","keywords":"Medicine; Hodgkin lymphoma; Salvage therapy; Lymphoma; Intensive care medicine; Oncology; Medical physics; Internal medicine; Chemotherapy","score_opus":0.05508825183610309,"score_gpt":0.40248809726720497,"score_spread":0.34739984543110186,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4400005506","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[6.0646556e-7,0.9901065,0.0000026937146,0.0047663385,0.0005186934,0.004180481,0.00003750202,0.00006592164,0.00032121822],"genre_scores_gemma":[7.668012e-7,0.98830587,0.0057662856,0.00055657496,0.0006389453,0.004422004,0.00017099312,0.00010338059,0.000035193476],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9976438,0.0001446366,0.00097398285,0.0007166548,0.00017992331,0.00034098103],"domain_scores_gemma":[0.99851054,0.00024213997,0.0004216388,0.000605344,0.000090899164,0.00012943201],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002768215,0.0006606827,0.005310561,0.00016459679,0.000042581323,0.000012439487,0.00015898944,0.00043107505,0.000046004414],"category_scores_gemma":[0.000034738052,0.0003687807,0.0010835067,0.0001484729,0.00013813037,0.00003090123,0.00006555594,0.00010515653,0.000018948089],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000009620104,0.0002043346,6.490732e-7,0.31748027,0.0007101293,0.00012643442,0.000096277385,8.984259e-11,4.177013e-8,0.003104178,0.006695634,0.67157245],"study_design_scores_gemma":[0.0008059968,0.00037846674,7.690056e-7,0.21627979,0.0016031365,0.0018653957,0.000031173953,3.1067725e-7,0.000007940472,0.000024741475,0.77878624,0.0002160678],"about_ca_topic_score_codex":0.0000016178103,"about_ca_topic_score_gemma":4.185763e-7,"teacher_disagreement_score":0.77209055,"about_ca_system_score_codex":0.00009853848,"about_ca_system_score_gemma":0.0002937065,"threshold_uncertainty_score":0.99987644},"labels":[],"label_agreement":null},{"id":"W4401091260","doi":"10.1080/17474086.2024.2385485","title":"Novel treatments for immune thrombocytopenia: targeting platelet autoantibodies","year":2024,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Platelet Disorders and Treatments","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Memorial University of Newfoundland; McMaster University","funders":"","keywords":"Medicine; Immune thrombocytopenia; Autoantibody; Platelet; Immune system; Immunology; Antibody","score_opus":0.0525106016778986,"score_gpt":0.41274882760750337,"score_spread":0.36023822592960475,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4401091260","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000035873322,0.993542,0.000051606447,0.00027249072,0.000627719,0.00441908,0.0002263688,0.00010438982,0.00075273064],"genre_scores_gemma":[0.0000015974197,0.9899844,0.0053597344,0.00024495396,0.00009979823,0.0012758356,0.0020074921,0.0001468049,0.00087939156],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.9965684,0.00006817558,0.0018540403,0.00075691706,0.00022221946,0.0005302415],"domain_scores_gemma":[0.9981633,0.00025624107,0.0007272182,0.00062685704,0.000117523,0.00010886334],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0002532559,0.00086591544,0.010292606,0.00022268559,0.00007802232,0.0000119310735,0.0002536457,0.00044884975,0.00017483743],"category_scores_gemma":[0.0002176588,0.00052727317,0.0021102715,0.0002835893,0.00012361868,0.00005529199,0.00014417678,0.0002978027,0.00022722268],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000017765049,0.0005430352,0.0000017732435,0.50971216,0.0050130594,0.00058162224,0.00005792566,3.0000735e-9,0.00000891904,0.0006672643,0.021766094,0.46163037],"study_design_scores_gemma":[0.00075931806,0.00023100866,2.5725146e-7,0.24410354,0.005952506,0.0047918954,0.00001086521,0.000001295509,0.000026564345,0.000029582034,0.74382305,0.00027012944],"about_ca_topic_score_codex":0.000026652755,"about_ca_topic_score_gemma":0.0000014533523,"teacher_disagreement_score":0.7220569,"about_ca_system_score_codex":0.00014594532,"about_ca_system_score_gemma":0.00040011303,"threshold_uncertainty_score":0.9997179},"labels":[],"label_agreement":null},{"id":"W4402381249","doi":"10.1080/17474086.2024.2396617","title":"Optimizing long-term joint health in the treatment of hemophilia","year":2024,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"","funders":"Ministry of Health, British Columbia; Ministero della Salute; European Commission","keywords":"Medicine; Intensive care medicine; Quality of life (healthcare); Arthropathy; Hemarthrosis; Pediatrics; Surgery; Alternative medicine; Osteoarthritis; Pathology; Nursing","score_opus":0.12294797114793674,"score_gpt":0.4677403675289576,"score_spread":0.3447923963810209,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4402381249","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.000008974939,0.9885707,0.0000022820607,0.006367353,0.00020621956,0.004336302,0.000018958817,0.000019151417,0.00047007442],"genre_scores_gemma":[0.000005260094,0.99771184,0.00045062532,0.00041178707,0.00013618839,0.0006494954,0.00024999617,0.000057690802,0.0003271188],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9959177,0.0006441638,0.0020490014,0.00053421175,0.00037113248,0.00048380374],"domain_scores_gemma":[0.9979482,0.00027100826,0.0005334789,0.0010496916,0.000068760106,0.00012883336],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00071938185,0.0005629203,0.00702401,0.0004305304,0.000033114233,0.0000057831176,0.0002861651,0.00026123965,0.000204731],"category_scores_gemma":[0.00007947331,0.00025248245,0.0015500556,0.0006508341,0.00020529475,0.000020142563,0.000063677595,0.00035861763,0.00009542244],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0000063622274,0.00078102,0.00001064908,0.4103551,0.00036267223,0.00050547847,0.0004826728,2.9252345e-9,2.998263e-7,0.00028999176,0.003405875,0.5837999],"study_design_scores_gemma":[0.00034385498,0.0010419514,0.0000029165362,0.354673,0.0007036626,0.0020298238,0.000021854023,4.7091984e-7,0.000011703472,0.000010588304,0.6410334,0.00012674632],"about_ca_topic_score_codex":0.000034102282,"about_ca_topic_score_gemma":0.000007936354,"teacher_disagreement_score":0.63762754,"about_ca_system_score_codex":0.00035063294,"about_ca_system_score_gemma":0.0009594786,"threshold_uncertainty_score":0.9999927},"labels":[],"label_agreement":null},{"id":"W4404322372","doi":"10.1080/17474086.2024.2429606","title":"Global prophylaxis trends in hemophilia: a macroeconomic analysis and its association with world development indicators","year":2024,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Hemophilia Society","funders":"","keywords":"Medicine; Intensive care medicine","score_opus":0.026750420263183423,"score_gpt":0.38633437103824275,"score_spread":0.35958395077505934,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404322372","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00035765395,0.99672776,6.385464e-7,0.00069978135,0.00006177227,0.0011051953,0.000023052879,0.000025668385,0.00099846],"genre_scores_gemma":[0.00033740402,0.9961528,0.00034792733,0.00008688513,0.00004158835,0.0005124678,0.0003064845,0.00003318679,0.002181266],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9970043,0.00022894934,0.0013030148,0.000691923,0.00035234043,0.00041950613],"domain_scores_gemma":[0.9987949,0.00010912337,0.00052709924,0.00033594406,0.00006344032,0.00016946155],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00059335225,0.0004954437,0.0050404146,0.0023422686,0.000031759126,0.000011878038,0.00016342134,0.0003470768,0.0003514027],"category_scores_gemma":[0.00008503429,0.00029137995,0.00056206563,0.004987366,0.00006473533,0.000036500307,0.00012622667,0.00039829954,0.0000987125],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00001531152,0.00016902301,0.00809455,0.16628554,0.0046333014,0.00034629632,0.000066562665,6.6443153e-9,4.33268e-8,0.00016322015,0.0020139432,0.8182122],"study_design_scores_gemma":[0.00039948247,0.00014221192,0.00034687348,0.09759126,0.005277892,0.00036147868,0.0000065648305,0.0000015502336,0.000008784565,0.000004204569,0.89554995,0.00030971775],"about_ca_topic_score_codex":0.0000152255425,"about_ca_topic_score_gemma":0.00018817214,"teacher_disagreement_score":0.89353603,"about_ca_system_score_codex":0.0011382217,"about_ca_system_score_gemma":0.0007075371,"threshold_uncertainty_score":0.9999538},"labels":[],"label_agreement":null},{"id":"W4404527095","doi":"10.1080/17474086.2024.2432358","title":"Rivaroxaban plus aspirin after lower–extremity revascularization","year":2024,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Peripheral Artery Disease Management","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Population Health Research Institute","funders":"","keywords":"Medicine; Rivaroxaban; Aspirin; Antithrombotic; Revascularization; Randomized controlled trial; Adverse effect; Intensive care medicine; Surgery; Internal medicine; Cardiology; Anesthesia; Warfarin; Myocardial infarction; Atrial fibrillation","score_opus":0.028546112154901524,"score_gpt":0.374020016958928,"score_spread":0.34547390480402645,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4404527095","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[8.392751e-7,0.9929479,0.0001387053,0.00086547225,0.00073224725,0.002852701,0.000024590323,0.000122036,0.0023155573],"genre_scores_gemma":[0.0000036449285,0.992696,0.00066810683,0.0036092578,0.00026363178,0.0012027262,0.00043875328,0.00010807281,0.0010098416],"study_design_codex":"systematic_review","study_design_gemma":"not_applicable","domain_scores_codex":[0.99634266,0.00033451762,0.0016669882,0.00083610433,0.0004399387,0.00037981546],"domain_scores_gemma":[0.99777585,0.00004771985,0.0004494586,0.0013789489,0.0001469165,0.00020113237],"candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.00037452622,0.0006838877,0.0051756967,0.00025277445,0.000024830104,0.000014023956,0.00031103412,0.00032582425,0.0016912865],"category_scores_gemma":[0.00020697893,0.00046567214,0.0019518525,0.0005260528,0.00013342766,0.00006196416,0.00033797225,0.00041013473,0.0010987901],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000010966016,0.000117428266,0.000004058988,0.60938257,0.00050343276,0.00067329506,0.000018993916,6.575772e-9,1.2125291e-7,0.0004225275,0.040172443,0.34869415],"study_design_scores_gemma":[0.00012544455,0.00003547243,0.0000016870924,0.33696178,0.0032135777,0.0005948509,0.0000017443045,0.0000033653832,2.9420377e-7,0.000019477267,0.6588087,0.00023357965],"about_ca_topic_score_codex":0.0000073995375,"about_ca_topic_score_gemma":0.0000017567899,"teacher_disagreement_score":0.6186363,"about_ca_system_score_codex":0.00029103333,"about_ca_system_score_gemma":0.00039062803,"threshold_uncertainty_score":0.9997795},"labels":[],"label_agreement":null},{"id":"W4406158969","doi":"10.1080/17474086.2025.2450223","title":"Characterizing the ideal patient for treatment with inotuzumab ozogamicin for relapsed/refractory acute lymphoblastic leukemia: a systematic literature review","year":2025,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Occupational Cancer Research Centre; Cancer Care Ontario","funders":"Pfizer","keywords":"Medicine; Refractory (planetary science); Lymphoblastic Leukemia; Gemtuzumab ozogamicin; Oncology; Intensive care medicine; Leukemia; Internal medicine; Pediatrics; Stem cell","score_opus":0.020119021962433252,"score_gpt":0.34597853935283435,"score_spread":0.3258595173904011,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4406158969","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[6.0552577e-7,0.96149707,0.0006132813,0.0011203457,0.00041431913,0.03573651,0.0004242342,0.00006934828,0.00012428904],"genre_scores_gemma":[0.0000012069595,0.9609779,0.0018131866,0.0044729137,0.00020201826,0.030283557,0.0014907686,0.00018196272,0.0005764618],"study_design_codex":"systematic_review","study_design_gemma":"systematic_review","domain_scores_codex":[0.99247885,0.00092024356,0.00367864,0.001231006,0.0007062787,0.0009849883],"domain_scores_gemma":[0.98789096,0.0060698953,0.002642561,0.0022284745,0.00091587944,0.00025221508],"candidate_categories":["metaepi_narrow"],"consensus_categories":["metaepi_narrow"],"category_scores_codex":[0.00093811745,0.0014554765,0.013844222,0.00042658765,0.00020493506,0.000033544613,0.00079870125,0.000739805,0.000033299286],"category_scores_gemma":[0.002283327,0.00068369776,0.0024830685,0.0010074738,0.00026444683,0.00010085545,0.00020995368,0.00047393327,0.000024057143],"study_design_candidate":"systematic_review","study_design_consensus":"systematic_review","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":true,"about_ca_system_consensus":true,"study_design_scores_codex":[0.00019070237,0.00017584083,8.447313e-8,0.8699745,0.0024326337,0.00021605015,0.00016804687,1.0248693e-8,0.00000273958,0.00033964793,0.01866742,0.107832305],"study_design_scores_gemma":[0.0013650033,0.0017984264,1.8518143e-8,0.5349409,0.008953049,0.0049605453,0.000016557517,0.000009569164,0.000010665697,0.000002955037,0.44766328,0.0002790166],"about_ca_topic_score_codex":0.000010524776,"about_ca_topic_score_gemma":0.000002602118,"teacher_disagreement_score":0.42899588,"about_ca_system_score_codex":0.004449772,"about_ca_system_score_gemma":0.007811624,"threshold_uncertainty_score":0.99981946},"labels":[],"label_agreement":null},{"id":"W4409922637","doi":"10.1080/17474086.2025.2500607","title":"Revolutionizing hypertension treatment: aprocitentan’s dual action against resistant hypertension","year":2025,"lang":"en","type":"editorial","venue":"Expert Review of Hematology","topic":"Blood Pressure and Hypertension Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Impact","funders":"","keywords":"Medicine; Resistant hypertension; Internal medicine; Cardiology; Intensive care medicine; Blood pressure","score_opus":0.04366818383536949,"score_gpt":0.3392756055108664,"score_spread":0.2956074216754969,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409922637","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00009376974,0.7579256,0.000009005363,0.0039942893,0.23505427,0.0011324788,0.00006716164,0.0001336027,0.0015897845],"genre_scores_gemma":[0.00026823988,0.8590122,0.0011494232,0.0055473275,0.13003048,0.00023118292,0.00118197,0.00008297656,0.002496183],"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","domain_scores_codex":[0.99548924,0.00031405952,0.0016429157,0.0010808178,0.00091721053,0.0005557585],"domain_scores_gemma":[0.99506867,0.0009955529,0.000812219,0.0012034734,0.0017498449,0.0001702647],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.0003904948,0.00081541744,0.005111019,0.00039726598,0.00029229454,0.000011898145,0.00017836368,0.0012677766,0.00007182476],"category_scores_gemma":[0.0020417862,0.0005831038,0.00088665436,0.00042433568,0.000224439,0.00009214491,0.00021709122,0.00072006497,0.000050731956],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003926149,0.000454284,0.000007898846,0.01940007,0.0011624637,0.00070949545,0.00005863054,2.769774e-8,0.0036602223,0.000053842283,0.96678805,0.007312427],"study_design_scores_gemma":[0.0018240359,0.00056296727,0.000008922246,0.05687487,0.003395174,0.00055557425,0.00015199796,0.0000076116294,0.0017587271,0.00001538269,0.9344441,0.00040058777],"about_ca_topic_score_codex":0.00017279793,"about_ca_topic_score_gemma":0.00003805911,"teacher_disagreement_score":0.105023794,"about_ca_system_score_codex":0.00021175516,"about_ca_system_score_gemma":0.00088379096,"threshold_uncertainty_score":0.99966204},"labels":[],"label_agreement":null},{"id":"W4412366402","doi":"10.1080/17474086.2025.2534704","title":"Factor first! Emergency department management of persons with hemophilia: a single-center study","year":2025,"lang":"en","type":"article","venue":"Expert Review of Hematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Blood Services; University of Calgary","funders":"","keywords":"Medicine; Emergency department; Guideline; Psychological intervention; Emergency medicine; Bleed; Quality management; Single Center; Pediatrics; Medical emergency; Internal medicine; Surgery; Management system","score_opus":0.03716599418714921,"score_gpt":0.36626585261466027,"score_spread":0.32909985842751105,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412366402","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.6221405,0.33165914,0.00016528563,0.01679385,0.00040832156,0.009060834,0.000036062724,0.00007042416,0.019665526],"genre_scores_gemma":[0.93356174,0.060993005,0.0017495443,0.00032238432,0.00002258893,0.00057032384,0.000038221173,0.000023923058,0.0027182752],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9984373,0.000082131504,0.00057808054,0.000317958,0.00032137995,0.0002631415],"domain_scores_gemma":[0.9990955,0.000040705898,0.00012611685,0.00052900077,0.00012954071,0.00007911711],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00012552523,0.00020111978,0.00093818957,0.00013666537,0.000047740028,0.0000014886693,0.0001438146,0.00005142979,0.0008714526],"category_scores_gemma":[0.000026161279,0.00012339871,0.00018044304,0.0003478237,0.00008936663,0.000025026466,0.000106347965,0.00008821978,0.000015991045],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000970961,0.029808197,0.73045003,0.1125161,0.0070394347,0.0017451837,0.0020345375,1.4691327e-7,0.00056186505,0.0034809986,0.098872334,0.012520239],"study_design_scores_gemma":[0.03949353,0.02519687,0.07892144,0.18015294,0.004475804,0.0016402791,0.010529216,0.000033575787,0.028275145,0.00020905436,0.62934935,0.001722771],"about_ca_topic_score_codex":0.000011608328,"about_ca_topic_score_gemma":0.000018470344,"teacher_disagreement_score":0.65152854,"about_ca_system_score_codex":0.00006619813,"about_ca_system_score_gemma":0.00005235809,"threshold_uncertainty_score":0.9541795},"labels":[],"label_agreement":null},{"id":"W4412611776","doi":"10.1080/17474086.2025.2535422","title":"Mesenchymal stromal cells for the prophylaxis of graft-versus-host disease after hematopoietic stem cell transplantation: a meta-analysis of randomized controlled trials","year":2025,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Mesenchymal stem cell research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of Alberta","funders":"","keywords":"Medicine; Mesenchymal stem cell; Graft-versus-host disease; Hematopoietic stem cell transplantation; Transplantation; Meta-analysis; Stem cell; Randomized controlled trial; Haematopoiesis; Disease; Immunology; Surgery; Internal medicine; Pathology; Biology","score_opus":0.10830186099737911,"score_gpt":0.4299351816037333,"score_spread":0.3216333206063542,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412611776","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0000049321966,0.9644814,0.0009977256,0.00041565287,0.0002981594,0.032730814,0.00076290837,0.000014509656,0.00029385928],"genre_scores_gemma":[0.0005198785,0.97792786,0.0006030257,0.0000895768,0.000057596466,0.019392,0.00022180156,0.000058047768,0.0011301888],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.97781414,0.009335593,0.009911257,0.00091960904,0.0014572158,0.0005621892],"domain_scores_gemma":[0.93562144,0.055538908,0.005660447,0.0018075941,0.0010947142,0.0002769143],"candidate_categories":["metaepi_narrow","metaepi_broad","insufficient_payload"],"consensus_categories":["metaepi_broad"],"category_scores_codex":[0.014580755,0.0010398037,0.07463312,0.0011298864,0.00006107819,0.000013425866,0.000810873,0.0004642446,0.0026948806],"category_scores_gemma":[0.004753972,0.00046448433,0.04357874,0.0016880571,0.0006719687,0.000044961547,0.00012090623,0.00043179054,0.00000781217],"study_design_candidate":"meta_analysis","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.071091704,0.00039821115,5.0923757e-7,0.6752646,0.2476598,0.00007128711,0.00014053045,4.8951205e-7,0.000010177192,0.00064246805,0.00045749068,0.0042627435],"study_design_scores_gemma":[0.063493304,0.00037214562,1.6078174e-7,0.036700208,0.8708793,0.00002435021,0.000051610146,0.000021835076,0.00031475857,0.0000069374873,0.02782741,0.00030795985],"about_ca_topic_score_codex":0.000027049016,"about_ca_topic_score_gemma":0.0000052176433,"teacher_disagreement_score":0.63856435,"about_ca_system_score_codex":0.000059070124,"about_ca_system_score_gemma":0.001634267,"threshold_uncertainty_score":0.9997807},"labels":[],"label_agreement":null},{"id":"W4412695930","doi":"10.1080/17474086.2025.2540401","title":"Does Down syndrome affect the prognosis of acute lymphoblastic leukemia? A systematic review and meta-analysis","year":2025,"lang":"en","type":"review","venue":"Expert Review of Hematology","topic":"Acute Lymphoblastic Leukemia research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Lymphoblastic Leukemia; Affect (linguistics); Meta-analysis; Intensive care medicine; Oncology; Leukemia; Internal medicine","score_opus":0.03156545313694228,"score_gpt":0.3752676643229227,"score_spread":0.34370221118598043,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412695930","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[2.2487242e-7,0.982096,0.000106398,0.0017513109,0.000081567356,0.015531984,0.00022594181,0.000045223944,0.00016131485],"genre_scores_gemma":[0.000009745344,0.9875659,0.00051306287,0.0022262225,0.00001706573,0.008413158,0.0001648721,0.00007794264,0.0010120565],"study_design_codex":"systematic_review","study_design_gemma":"meta_analysis","domain_scores_codex":[0.98910207,0.0030052422,0.0049029244,0.0011887397,0.0011087132,0.00069233443],"domain_scores_gemma":[0.98691344,0.0061047887,0.003136275,0.0029851124,0.0006093718,0.0002510296],"candidate_categories":["metaepi_narrow","metaepi_broad"],"consensus_categories":[],"category_scores_codex":[0.0028205523,0.0012658566,0.04256119,0.00085911626,0.00009454984,0.000017890765,0.0012764403,0.0005584082,0.00076797366],"category_scores_gemma":[0.003987818,0.0004670021,0.008748652,0.0035048625,0.00073561637,0.00006918135,0.00070920243,0.00058846787,0.000043529206],"study_design_candidate":"systematic_review","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.000004623049,0.00006967911,5.276693e-7,0.7517305,0.24368195,0.00019568538,0.00001833471,8.538899e-9,1.0894574e-7,0.00018552692,0.003421029,0.0006920153],"study_design_scores_gemma":[0.00015271913,0.00011033463,1.4276746e-7,0.44879153,0.5337693,0.0038946378,0.000005557627,0.0000025238419,0.0000028945742,0.000004413765,0.013056075,0.00020987037],"about_ca_topic_score_codex":0.000056023953,"about_ca_topic_score_gemma":0.0000043737905,"teacher_disagreement_score":0.302939,"about_ca_system_score_codex":0.00062719954,"about_ca_system_score_gemma":0.0029188925,"threshold_uncertainty_score":0.99977815},"labels":[],"label_agreement":null},{"id":"W4412826219","doi":"10.1080/17474086.2025.2542867","title":"Cognitive impairment in hematology patients planned for chimeric antigen receptor T-cell therapy","year":2025,"lang":"en","type":"article","venue":"Expert Review of Hematology","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Medicine; Chimeric antigen receptor; Hematology; Oncology; Internal medicine; Immunology; Immunotherapy; Cancer","score_opus":0.016132768515435242,"score_gpt":0.3490958760747081,"score_spread":0.33296310755927283,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4412826219","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.28593194,0.68970865,0.0004528354,0.009050787,0.0011201217,0.009731451,0.00007646612,0.0000838008,0.0038439315],"genre_scores_gemma":[0.5390768,0.43661544,0.0016100218,0.018484605,0.00007662112,0.0031933833,0.00041709855,0.000064002976,0.00046198256],"study_design_codex":"observational","study_design_gemma":"not_applicable","domain_scores_codex":[0.9978442,0.00016292481,0.0009265741,0.00046420147,0.00016133285,0.00044074192],"domain_scores_gemma":[0.99851245,0.00047144157,0.0003299995,0.0002413583,0.0003796964,0.00006508067],"candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.00024133614,0.0003107627,0.0016462549,0.00028222334,0.000060866034,0.0000022268157,0.00012017222,0.00015365095,0.00025291962],"category_scores_gemma":[0.00042633718,0.0002512673,0.0002638772,0.00044327296,0.00019313913,0.0000410775,0.000074312265,0.00016878365,0.00003113986],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.011429642,0.011854945,0.44759896,0.041737247,0.0024335545,0.00006795588,0.0028529065,1.9194077e-7,0.0012068859,0.0019468683,0.42270017,0.056170665],"study_design_scores_gemma":[0.108704455,0.022809723,0.10758265,0.19311647,0.00091152434,0.0003436759,0.0040970217,0.000059882957,0.21239671,0.00096062024,0.34664345,0.002373817],"about_ca_topic_score_codex":0.00002563567,"about_ca_topic_score_gemma":0.000006444869,"teacher_disagreement_score":0.3400163,"about_ca_system_score_codex":0.00010198937,"about_ca_system_score_gemma":0.0001850054,"threshold_uncertainty_score":0.999994},"labels":[],"label_agreement":null},{"id":"W4413772971","doi":"10.1080/17474086.2025.2554652","title":"Clinical decisions and factors influencing the management of persons with hemophilia requiring antithrombotic therapy: a qualitative study","year":2025,"lang":"en","type":"article","venue":"Expert Review of Hematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Ottawa; Ottawa Hospital; University of Calgary","funders":"Canadian Hemophilia Society","keywords":"Medicine; Antithrombotic; Intensive care medicine; Internal medicine","score_opus":0.10838896773887388,"score_gpt":0.4944768954409317,"score_spread":0.3860879277020578,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413772971","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.8839422,0.11163398,0.00003944125,0.0023143208,0.000039710267,0.0014239423,0.0000010809224,0.000009814271,0.00059554516],"genre_scores_gemma":[0.919574,0.07880705,0.001121925,0.0002839719,0.000006836691,0.000055468805,0.0000020753976,0.000008688652,0.00013999276],"study_design_codex":"observational","study_design_gemma":"qualitative","domain_scores_codex":[0.9982665,0.00041087417,0.0006246053,0.00027006003,0.00025460692,0.00017336171],"domain_scores_gemma":[0.9983427,0.00088299013,0.00014553704,0.00045267888,0.00012026005,0.00005586146],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009307672,0.00014838246,0.00096633,0.00009769551,0.00008499704,0.0000035177395,0.00013662456,0.000047070556,0.000036227928],"category_scores_gemma":[0.00016598887,0.00006791145,0.00012537946,0.00034706728,0.00041986603,0.00003161291,0.000108352826,0.00015782891,0.0000015993609],"study_design_candidate":"observational","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0009496861,0.0056083323,0.7603883,0.020922644,0.010640916,0.00051915215,0.13138749,3.2393513e-7,0.00046874586,0.01397888,0.0028989878,0.05223654],"study_design_scores_gemma":[0.014027995,0.008561167,0.2835416,0.12257892,0.0019307531,0.00026360867,0.5599326,0.000034596233,0.0028286783,0.0006961182,0.005024353,0.0005796098],"about_ca_topic_score_codex":0.000029584056,"about_ca_topic_score_gemma":0.000004977647,"teacher_disagreement_score":0.47684672,"about_ca_system_score_codex":0.000019051873,"about_ca_system_score_gemma":0.00008612169,"threshold_uncertainty_score":0.27693486},"labels":[],"label_agreement":null},{"id":"W4415842547","doi":"10.1080/17474086.2025.2574715","title":"Quantifying the optimal factor VIII levels to achieve patient-centric and clinician-relevant outcomes among people with hemophilia A: a SHELF elicitation study","year":2025,"lang":"en","type":"article","venue":"Expert Review of Hematology","topic":"Hemophilia Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Canadian Hemophilia Society","funders":"Swedish Orphan Biovitrum","keywords":"Off the shelf; Clinical trial; MEDLINE; Risk factor; Risk assessment","score_opus":0.04957277852374742,"score_gpt":0.3999604426526519,"score_spread":0.3503876641289045,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415842547","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.94781697,0.035826527,0.0001075594,0.012669686,0.00012535139,0.003284871,0.000005568593,0.000026193105,0.00013728655],"genre_scores_gemma":[0.9910114,0.006093422,0.0008700851,0.001542268,0.000017504772,0.0002656478,0.000007816146,0.000018135746,0.00017375911],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9979534,0.00026732835,0.0006976055,0.00039968797,0.0003544343,0.0003275119],"domain_scores_gemma":[0.9984003,0.0006490633,0.0001624198,0.00046632937,0.00020607052,0.00011586859],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003471246,0.00024411014,0.0011454162,0.00019886594,0.00014507736,0.000012817455,0.00014682808,0.00007632436,0.000062931555],"category_scores_gemma":[0.0006667538,0.000121264944,0.00012773913,0.00055502646,0.00012028946,0.00006284984,0.00013375995,0.00020461393,0.000015720885],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00031772893,0.0010108871,0.9649964,0.0028437166,0.0005313716,0.000089059635,0.0052084364,6.267246e-7,0.00013999679,0.00036608212,0.0011054622,0.023390256],"study_design_scores_gemma":[0.004491693,0.0049030357,0.96816057,0.009883994,0.00048147075,0.00014835123,0.0069482685,0.000121437035,0.0012483108,0.00002571811,0.0032104568,0.0003766812],"about_ca_topic_score_codex":0.00009783968,"about_ca_topic_score_gemma":0.0001201584,"teacher_disagreement_score":0.043194406,"about_ca_system_score_codex":0.000045657198,"about_ca_system_score_gemma":0.00012944175,"threshold_uncertainty_score":0.4945041},"labels":[],"label_agreement":null},{"id":"W7117141018","doi":"10.1080/17474086.2025.2610282","title":"Improving transfusion access through improved policy: a call for a less fragmented blood supply","year":2025,"lang":"en","type":"article","venue":"Expert Review of Hematology","topic":"Blood donation and transfusion practices","field":"Business, Management and Accounting","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Canadian Blood Services; University of Toronto","funders":"","keywords":"Reimbursement; Interoperability; Psychological intervention; Data sharing; Corporate governance; Blood supply","score_opus":0.02563344983874305,"score_gpt":0.33576347762796205,"score_spread":0.310130027789219,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W7117141018","genre_codex":"review","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"codex-gemma-dda1882f352a","genre_candidate":"empirical","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.027205862,0.40874767,0.14467545,0.35069,0.0037274482,0.011934112,0.000058599853,0.0008282669,0.052132588],"genre_scores_gemma":[0.5770804,0.16892943,0.014928756,0.2329234,0.0014567265,0.0030751282,0.00038250553,0.00017047071,0.0010531602],"study_design_codex":"theoretical_or_conceptual","study_design_gemma":"not_applicable","domain_scores_codex":[0.9983579,0.000035651512,0.000743777,0.00040692443,0.00015589427,0.00029988488],"domain_scores_gemma":[0.9985868,0.00020706319,0.00042064264,0.00032890425,0.0004437839,0.0000128334905],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003839959,0.00023812955,0.0007108023,0.00026836857,0.00017512325,0.00008509727,0.0004732332,0.00012964613,0.00021626047],"category_scores_gemma":[0.00065290637,0.00019839418,0.00022370015,0.0008494372,0.000069700065,0.0011079154,0.00013689778,0.00013586314,0.0000073300057],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00047427564,0.002105759,0.0029122035,0.100054376,0.00066527835,0.000016714594,0.00035398893,9.944939e-7,0.01948291,0.67447335,0.051008325,0.1484518],"study_design_scores_gemma":[0.006779382,0.00007164184,0.00025814184,0.009520293,0.00086475007,0.000042531392,0.00035234008,0.0014397762,0.022984395,0.0048148325,0.9521892,0.000682682],"about_ca_topic_score_codex":0.0028783977,"about_ca_topic_score_gemma":0.0003078666,"teacher_disagreement_score":0.9011809,"about_ca_system_score_codex":0.000012479231,"about_ca_system_score_gemma":0.0001336582,"threshold_uncertainty_score":0.80902797},"labels":[],"label_agreement":null}]}